In addition to thousands of research papers related to resveratrol (RSV), approximately 300 review articles have been published. Earlier research tended to focus on pharmacological activities of RSV related to cardiovascular systems, inflammation, and carcinogenesis/cancer development. More recently, the horizon has been broadened by exploring the potential effect of RSV on the aging process, diabetes, neurological dysfunction, etc. Herein, we primarily focus on the in vivo pharmacological effects of RSV reported over the past 5 years (2009)(2010)(2011)(2012)(2013)(2014). In addition, recent clinical intervention studies performed with resveratrol are summarized. Some discrepancies exist between in vivo studies with animals and clinical studies, or between clinical studies, which are likely due to disparate doses of RSV, experimental settings, and subject variation. Nevertheless, many positive indications have been reported with mammals, so it is reasonable to advocate for the conduct of more definitive clinical studies. Since the safety profile is pristine, an added advantage is the use of RSV as a dietary supplement. This article is part of a Special Issue entitled: Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes.
Introduction
Resveratrol (RSV) was first isolated in 1939 by Takaoka from Veratrum grandiflorum Loes. fil. (the root of the white hellebore) [1] . It is speculated that the name resveratrol was derived from the combination of its chemical structure and plant source used for isolation: a resorcinol derivative or polyphenol in the resin, occurring in Veratrum species which contains hydroxyl (-OH) groups (-ol). In addition to the most popular name, resveratrol, further nomenclature includes trans-resveratrol, (E)-resveratrol, 3,4′,5-trihydroxy-trans-stilbene, 3,4′,5-stilbenetriol, (E)-3,4′,5-trihydroxystilbene, trans-3,5,4′-trihydroxystilbene, 5-[(1E)2-(4-hydroxyphenyl)ethenyl]1,3-benzenediol, (E)2-(3,5-dihydroxyphenyl)1-(4-hydroxyphenyl)ethane, (E)5-(p-hydroxystyryl)resorcinol, Bioforte™, Regu®-Fade (for skin), resVida™, and SRT 501.
As a defense mechanism in plants, the production of RSV, one of the phytoalexins, can be triggered in response to fungi, rhizobacteria, UV irradiation, metallic salts, methyl jasmonate, etc. The main enzyme responsible for RSV biosynthesis is stilbene synthase which condenses one p-coumaroyl-CoA (4-coumaroyl-CoA) and three molecules of malonyl-CoA [2] . Stilbene synthase encoding genes have been identified in grapevine, pine, Arachis hypogea, Parthenocissus henryana, Vitis riparia cv Gloire de Montpellier, Sorghum, etc. [3] .
Despite the early discovery, RSV gained little attention until an article coining the phrase 'the French paradox' was published, in which it was suggested that people of France, who consume a relatively high level of saturated fat, had a relatively low mortality from coronary heart disease, presumably as a result of wine consumption [4] . Later, RSV was touted as an active ingredient in red wine responsible for reduced serum lipids [5] , but of course the concentration of RSV in wine is relatively low [6] , and grapes are known to contain over 1600 phytochemicals [7] . As shown in Fig. 1 , there has been an enormous upsurge of studies investigating the characteristics of RSV since 1997, undoubtedly due to the publication or our paper reporting cancer chemopreventive potential with a number of model systems [8] .
Based on a search using SciFinder® [accessed July 18, 2014, using the RSV chemical structure (CAS 501-36-0)], 219 commercial sources are available and 679 reactions to yield RSV have been published. A large number of patents have been filed that are related to the effects of RSV in therapeutic, cosmetic and nutraceutical applications [9] . The response of the nutraceutical industry has been robust. Many dietary supplements containing RSV as a single component or in combination with other ingredients are on the market. Unit doses range from about 0.2 to 1000 mg (Google search, July 19, 2014) . In some products RSV is encapsulated in liposomal formulations, micronized, or filled as a liquid capsule, ostensibly to improve the absorption.
In addition, a wide array of compounds and extracts are used in combination with RSV, including: compounds such as glucosamine, flavonoids (e.g., quercetin, catechins, rutin, anthocyanins, and proanthocyanidins), stilbenoids (e.g., piceid), phenolic acids (e.g., ellagic acid), vitamins (e.g., vitamins B6, B12 and C, folic acid, and coenzyme Q10), phosphatidylcholine, piperine, tocotrienols, lutein, lycopene, fatty acids (e.g., docosahexaenoic acid, eicosapentaenoic acid), L-carnitine, and reduced L-glutathione; extracts from kelp, acai berry, blueberry, cherry, cranberry, pomegranate, olive, citrus fruits, melon, grape, French red wine, turmeric rhizome, black pepper fruit, potato, or calamari oil. Also, RSV has been used as an active ingredient in skin care products, with vitamin C, calcium, methylsulfonylmethane, polyphenols, or proanthocyanidins.
Although scores of in vitro studies have added to our understanding of the vast biological potential of RSV, it is common to use high concentrations that may not be of physiological relevance. Since RSV is known to have poor bioavailability in that it is rapidly metabolized and excreted, it is expected that the results of many in vitro studies will not have a good correlation with in vivo studies. Here, the discussion is limited to the in vivo biological effects of RSV, excluding work in which extracts or mixtures of compounds were investigated.
The review is largely based on a PubMed search using the search terms as 'resveratrol and animal model', 'resveratrol and in vivo', or 'resveratrol and animal study'. A literature search using SciFinder® (research topic: resveratrol, document type: review, publication year: -2008, accessed November 22, 2014) resulted in 244 review articles that include "resveratrol" in the titles. As an attempt to avoid redundancy, this article focuses on in vivo studies that were published during the time period of 2009 to 2014.
Carcinogenesis/cancer
Studies on the cancer chemopreventive effect of RSV increased dramatically following the paper published in 1997 describing the ability of RSV to inhibit skin carcinogenesis in an animal model [8] . Since comprehensive reviews on the cancer chemopreventive and anti-cancer potential of RSV have been published, we currently summarize data appearing over the past 5 years. Molecular alterations observed with different carcinogenesis/cancer models (including lung, breast, prostate and colon) are illustrated in Fig. 2. 
Skin
The first report on the cancer chemopreventive potential of RSV was against skin carcinogenesis [8] . In rodent models, skin cancer can be induced by the treatment with 7,12-dimethylbenz[a]anthracene (DMBA) plus 12-O-tetradecanoylphorbol-13-acetate (TPA), benzo[a]pyrene (BP), and UV irradiation [10, 11] . To evaluate the skin cancer chemopreventive or anti-cancer capacity of RSV, in vivo studies have been conducted using DMBA/TPA [8, [12] [13] [14] [15] [16] , DMBA alone [17] [18] [19] [20] [21] , TPA alone [22] [23] [24] , DMBA/ croton oil [25] , UVB exposure [26] [27] [28] [29] , BP [18] , and xenograft [30] models. Topical application of RSV is the most commonly used route of treatment in skin cancer models. In DMBA/TPA models, RSV treatment reduced the incidence [8, [12] [13] [14] [15] , multiplicity [8, 12, 14, 15] , and tumor volume [14] [15] [16] , and delayed the onset of tumorigenesis [14] . At biomarker levels, RSV induced apoptosis: RSV decreased the expression levels of Bcl-2 while it increased p53 and Bax. Also, RSV enhanced the release of cytochrome c, induced apoptotic protease-activating factor-1(APAF-1), and cleaved caspase-9,-3, and poly (ADP-ribose) polymerase (PARP) [14] . On the other hand, it decreased cell survival-related proteins including phosphatidylinositol-3-kinase (PI3K) and Akt [17] , and inflammatory markers including interleukin (IL)-6, cyclooxygenase-2 (COX-2), and cJun [16] .
With UVB models, RSV decreased bi-fold skin thickness [26, 27] , hyperplasia [27] , infiltration of leukocytes [27] , and incidence [28] , and delayed the onset of tumorigenesis [28] . In addition, biomarkers were affected by RSV treatment. Activities of ornithine decarboxylase (ODC) [26] and COX [26] and expression levels of ODC [26] , proliferating cell nuclear antigen (PCNA) [27] , cyclin-dependent kinase (CDK)2, CDK6, and cyclinD2 [27] , mitogen-activated protein kinase kinase (MEK) [27] , extracellular signal-regulated kinase (ERK) [27] , survivin, and phosphorylated (p-)survivin were downregulated. On the other hand, the expression of p21 [27] , p53 [27] , and Smac/DIABLO [28] was upregulated. Furthermore, RSV exerted the antioxidant effect with the reduction of H 2 O 2 and lipid peroxidation in the skin [26] .
Notably, oral administration of RSV, but not topical treatment, also resulted in positive effects, including decreases in the tumor multiplicity [29] and volume [29] , and delay in the onset of tumorigenesis [29] . The anti-tumor effect of RSV was associated with decreased expression levels of TGF-β1 [29] and Rictor [31] , and increased expression levels of E-cadherin [29] .
With the human cutaneous skin squamous carcinoma A431 cell line xenograft model, tumor volume was decreased by RSV treatment, along with increased expression levels of p53 and ERK [30] , and decreased levels of survivin [30, 32] . Although ERK is considered as a proliferation and survival protein in general, ERK was also reported to form a complex with p53, leading to an increase in p53 phosphorylation and expression [30] . Also, RSV enhanced the activation of caspase-3 [32] . In addition, the antitumor effect of RSV was reduced with genetically engineered animals including TLR4 deficient C3H/HeJ mice in the DMBA model [19] and Sirtuin 1 (Sirt1)-null mice in the DMBA/TPA model [15] .
Oral gavage of RSV inhibited the growth of a mouse melanoma (B16BL6 cell line) xenograft carried in mice, with decreased expression of Akt [33] . In another xenograft model with A2058 human melanoma cells, intratumoral injection of RSV reduced tumor volume and this was associated with inhibition of STAT3-DNA methyltransferase 1 (DNMT1) complex formation and the sequential decrease in the methylation of several tumor-suppressor gene (PTPN6, CDKN2A, and SOCS3) promoters [34] . On the other hand, tumor growth of other melanoma cell lines, including B16M [35] , A375 [36] , and Duke melanoma 738 xenografts in mice, was not attenuated by RSV, demonstrating limited potential as an anti-melanoma agent [37] . Topical administration of RSV reduced UVB-induced hyperpigmentation which is related to melanoma formation with a decrease in tyrosinase-related protein 2 in male brownish guinea pigs (KIWA:A1) [38] .
The experimental conditions and outcomes with individual animal models are listed in Table 1 .
Breast
Breast cancer is expected to be the most commonly diagnosed type of cancer and to rank second in cancer mortality among women in the United States in 2014, when excluding basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder [39] . RSV has displayed cancer chemopreventive and anti-cancer properties in certain types of breast cancer animal models. Chemically-induced mammary gland carcinogenesis models using DMBA [8] , N-methyl-Nnitrosourea (MNU) [40] , or estradiol [41] , as well as spontaneous mammary tumor models using HER-2/neu-overexpressed [42] or Brca1-mutated (K14cre; Brca1 F/F ; p53 F/F ) mice [43] , have been used to evaluate the preventive or curative effect of RSV. Among around 20 papers found from PubMed or SciFinder searches, the DMBA-induced model (7 publications) or xenograft in the hind flank region or the mammary fat pad (6 publications) is most commonly used.
Although some controversial studies exist indicating that RSV has no effect [43, 44] or even enhances tumorigenesis [45, 46] , the majority of studies found that RSV can prevent tumorigenesis [34, 40, 42, [47] [48] [49] [50] [51] . In DMBA-induced models, dietary supplementation with RSV reduced mammary tumor incidence associated with the alteration of biochemical markers in mammary tissue. RSV reduced the levels of lipid peroxidation [4-hydroxy-2-nonenal (4-HNE)] and DNA-single-strand breaks, inhibited the expression of COX-2, matrix metalloproteinase (MMP)-9, 5-lipoxygenase (5-LOX), nuclear factor-κB (NFκB), leukotriene B 4 (LTB 4 ; a main product of 5-LOX which can enhance proliferation and suppress apoptosis), and cyclin D1, and attenuated the activation of NFκB, while it increased caspase-3 activity and TGF-β1 expression in mammary tissues of rats [52, 53] . With breast cancer cell implanted fat pad models using cigarette smoke condensate-transformed MCF-10A-Tr cells [50] or SUM159 cells [51] , RSV downregulated the expression of cell proliferation/survival-related proteins (PI3K, β-catenin, cyclin D1, and PCNA), DNA repair-related proteins (DNA-ligase-I, Fen-1, Pol-δ, and Pol-ε), and anti-apoptotic protein (Bcl-xL), while it upregulated tumor suppressor gene, p21, and proapoptotic protein, Bax, in mammary tissue of mice [50, 51] .
Hyper-lipogenesis is a hallmark of cancer cell physiology [30] . RSV treatment suppressed the tumor growth of cancer stem-like cells isolated from MDAMB231Luc in a mouse xenograft model, accompanied by the suppression of fatty acid synthase (FAS) which is related [30] to lipogenesis and over-expressed in various cancers. Consequently, proapoptotic markers including death associated kinase 2 and BCL2/ adenovirus E1B 19 kDa protein interacting protein 3, which are inhibited by FAS via ceramide synthesis, were induced by RSV [54] .
In an estradiol-induced model with female ACI rats, RSV decreased the expression level of DNMT3b, miR21, -129, -204, and -489 in tumor but increased these factors in normal tissues [41] . Moreover, with rats, RSV prevented mammary carcinogenesis of offspring. Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to CpG methylation of the breast cancer-1 (BRCA-1) gene and the subsequent reduction of BRCA-1 expression in the mammary tissue of offspring. Pretreatment with RSV partially reversed the changes by upregulating the expression of aromatic hydrocarbon receptor (AhR) repressor (AhRR) [55] .
A summary of studies is given in Table 2 .
Prostate
Prostate cancer is expected to be the most commonly diagnosed type of cancer and to rank second in cancer mortality among men in the United States in 2014, when excluding basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder [39] . Two experimental models to evaluate the cancer chemopreventive or anti-cancer capacity of RSV were employed primarily, including spontaneous tumor models using genetically modified rodents or xenograft models in which prostate cancer cells were inoculated into the flank area subcutaneously, or into the prostate.
With transgenic mouse models, dietary consumption of RSV attenuated prostate tumorigenesis. For instance, with the transgenic adenocarcinoma mouse prostate (TRAMP) model, RSV reduced grade 4 and 6 lesions of prostatic adenocarcinoma and decreased cell proliferation in the dorsolateral (DLP) and ventral prostate (VP) [56] . With the transgenic rat for adenocarcinoma of prostate (TRAP) model, RSV reduced the content of prostatic neoplastic lesions [57, 58] with inhibiting cell proliferation in the ventral prostate [58] . With prostate-specific phosphatase and tensin homolog (PTEN)-knockout mouse model, the incidence of both mouse prostatic intraepithelial neoplasia (mPIN) lesions [59] and high-grade prostatic intraepithelial neoplasia (HGPIN) lesions [60] was reduced by RSV, with a decrease in p-S6 kinase (S6K) and an increase of Sirt1 in prostate tissue. These results suggest that RSV exerts an anti-tumor effect via Sirt1/S6K-mediated autophagy [60] .
In xenograft models with androgen receptor (AR)-positive LNCaP or LNCaP-Luc human prostate cancer cells, pretreatment and posttreatment of RSV upon cell inoculation exhibited different efficacies. Treatment with RSV via the diet (6 or 12 mg/kg/day) [61] and oral gavage (50 mg/kg/day, every other day) [62] starting 2 weeks prior to inoculation of cells in nude mice delayed tumor growth, whereas supplementation with RSV (50 mg/kg/day) in the Western diet 3 weeks after inoculation in SCID mice had no effect on survival [63] . In castrated nude mice, RSV (4 g/kg diet) intervention just 1 day after implantation, reduced tumor volume, and this was associated with a reduction of β-catenin-mediated AR function via downregulating the expression of hypoxia-inducible factor 1-alpha (HIF-1α) [64] .
With AR-negative PC-3 human prostate cancer cell xenografts in the flank area of mice, post-treatment of oral RSV (30 mg/kg/day) reduced tumor volume with decreases in tumor cell proliferation and neovascularization and induction of apoptosis [65] .
In addition, intraperitoneal post-treatment with RSV (25 mg/kg/day) reduced the tumor volume with PC-3 cell xenografts in the prostate of mice [66] . However, the anti-tumor effect of RSV diminished in xenografts with sphingosine kinase-1 (SphK1)-transfected PC-3 cells, which demonstrated that SphK1, an enzyme facilitating the conversion of the sphingosine (proapoptotic) into S1P (prosurvival), is a target for RSV. Also, intraperitoneal post-treatment of RSV (50 mg/kg/day) in orthotopic Du145 cell xenografts in the prostate reduced tumor growth, progression, local invasion, and spontaneous metastasis. The effect of RSV decreased with metastasis-associated protein 1 (MTA1)-knockdown Du145 cell xenografts indicating that MTA1 plays a crucial role in anti-tumor effect of RSV [67] .
Experimental conditions and outcomes with individual animal models are listed in Table 3 .
Lung
Lung cancer is expected to be the second most commonly diagnosed type of cancer and to rank first in cancer mortality among men and women in the United States in 2014, when excluding basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder [39] . In animal models, a variety of agents are known to induce lung carcinogenesis, including nitrosamine 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), diethylnitrosamine (DEN), BP, vinyl carbamate, uracil mustard, urethane, and MNU [11] . Using BP plus NNK [69] or BP only [70] in mouse models, RSV supplemented in the diet had no effect on lung tumor multiplicity [69] , the expression levels of CYP1A1 and CYP1B1 [70] , or the level of BP protein adduct [70] . On the other hand, RSV treatment in the BP-induced mouse lung carcinogenesis model reduced the level of BP diolepoxide (BPDE)-DNA adduct [71] , improved ultrahistoarchitecture [72] , decreased the development of tumor nodules with increased pulmonary caspase-3 and -9 activities, and decreased glucose uptake/turnover and serum lactate dehydrogenase (LDH) activity (It is elevated in cancer cells involving cancer cell metabolism) and p-p53 levels at Ser15 (Its hyperphosphorylation can lead to the inactivation of p53) [73] .
With Lewis lung carcinoma cell xenograft models, RSV treatment attenuated tumor growth [74] [75] [76] [77] , and this was associated with increased apoptosis accompanied by elevated TUNEL-positive cells [75, 76] and caspase-3 activity [75] and reduced angiogenesis-related protein, factor VIII [75] in tumors, and decreased oxidative stress along with an increase in superoxide dismutase (SOD) activity and a decrease in malondialdehyde (MDA) content in serum [77] .
Over the past 5 years, it has been found that RSV treatment attenuated the growth of A549 [78, 79] and MSTO-211H [80] xenografts in mice. Several biochemical/molecular alterations occurred with RSV administration: RSV suppressed tumor fluorodeoxyglucose ( 18 F-FDG) uptake (a marker for the tissue uptake of glucose) in Lewis lung carcinoma xenograft mice [81] , increased cleavage of caspase-3 (apoptosis marker), and reduced specificity protein 1 (Sp1; highly expressed in various cancers) in MSTO-211H-bearing mice [80] . Forkhead box protein C2 (FOXC2) was reported to enhance tumor metastasis and induce epithelial to mesenchymal transition (EMT). One study with mice demonstrated that the anti-tumor effect of RSV in A549 xenografts was diminished in FOXC2-overexpressing A549 xenografts, suggesting that RSV possibly exerts anti-tumor activity via FOXC2 [79] .
The experimental conditions and outcomes with individual animal models are listed in Table 4 .
Colon
Colorectal cancer is expected to be the third most commonly diagnosed type of cancer and rank third in cancer mortality among men and women in the United States in 2014, when excluding basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder [39] . In addition to using genetically modified animals such as Apc Min/+ mice and Apc Pirc/+ rats, chemical carcinogens induce colon cancer, including azoxymethane (AOM), AOM plus dextran sulfate sodium (DSS), 2-amino-3-methylimidazo[4,5-f]quinoline, 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine, and 1,2-dimethylhydrazine (DMH) [10, 11, 82] . The histopathological and pathophysiological manifestations/features of colon cancers can be observed, including hyperplasia, aberrant crypt foci (ACF), adenoma, and adenocarcinoma [82] . In AOM-or AOM plus DSS-induced models, oral administration (in the diet or gavage) of RSV reduced the incidence [83, 84] , multiplicity [83, 85, 86] , and individual size [85] of ACF in rodent models with the alteration of biomarkers. RSV increased the expression of Bax [85] , p53 and p-p53 at Ser15 [83] , heme oxygenase-1 (HO-1) [86] , glutathione reductase (GR) [86] , and nuclear localized nuclear factor (erythroid-derived 2)-like 2 (Nrf2) [86] , whereas it decreased the expression of inducible nitric oxide synthase (iNOS) [83, 86] , COX-2 [83, 86] , tumor necrosis factor alpha (TNF-α) [83] , aldose reductase [86] , NFκB [86] , and p-protein kinase C-β2 (PKC-β2) [86] . It is suggested that RSV down-regulated aldose reductase-dependent activation of PKC-β2 and NFκB, with a subsequent decrease in the expression level of iNOS and COX-2 [86] . In DMH-induced models, RSV reduced the incidence [87] , multiplicity [87] [88] [89] , size [87, 88] of ACF, histopathological lesions [87] , and DNA damage in leukocytes [90] . The anti-tumor effect of RSV against colon carcinogenesis is accompanied by the alteration of enzyme activities: In rat models, the activities of antioxidant enzymes including SOD and catalase (CAT) in the intestine/colon [88] , liver [91] , and erythrocytes [90] were increased, while the activities of biotransforming enzymes including β-glucuronidase, β-glucosidase, β-galactosidase, mucinase, and nitroreductase in colonic mucosal and fresh fecal samples were decreased [87] . In addition, the expression levels which are altered by DMH in rats were normalized by RSV treatment: RSV reduced the expression levels of COX-2, ornithine decarboxylase (ODC), heat shock protein (Hsp)27, Hsp70, and MUC1 in colonic mucosa [92] , and β-catenin in ACF [93] , whereas it induced the expression levels of caspase-3 in colonic mucosa [92] and glutathione, reduced state (GSH), in the intestine/colon [88] , liver [91] , erythrocytes [90] , and plasma [90] . With genetically modified mouse models (e.g. Apc Min/+ mice [94] [95] [96] , and mice with APC locus knockout and activated Kras [97] ), supplementation with RSV inhibited the formation of colon tumors [94] [95] [96] [97] and dysplasia occurrence [96] . At the mRNA level, RSV downregulated i) cell survival-related mRNA (cyclins D1 and D2, DP-1 transcription factor, and Y-box DNA-binding protein), and upregulated ii) recruitment and activation of immune cell-related mRNAs (cytotoxic T lymphocyte Ag-4, leukemia inhibitory factor receptor, and monocyte chemotactic protein 3), and iii) carcinogenic process and tumor expansion-related mRNA (tumor susceptibility protein TSG101, TGFβ, inhibin-βA subunit, and desmocollin 2) in small intestinal mucosa [94] . At the miRNA level, RSV induced the expression of miR-96, which regulates Kras translation [97] . In addition, RSV reduced levels of PGE 2 in the intestine [95] . The experimental conditions and outcomes with individual animal models are listed in Table 5 .
Liver
Hepatocarcinogenesis can be induced by DEN, DEN plus phenobarbital, aflatoxin, CCl 4 , thioacetamide, peroxisome proliferators, and a choline deficient diet in animal models. Also, it can be observed in genetically engineered models including hepatitis virus transgenic and Mdr2 knockout models [99] . RSV treatment, either at early or advanced stages of hepatocarcinogenesis, has been shown to be effective. The experimental conditions and outcomes with individual animal models are listed in Table 6 .
From the late 1990s, the chemopreventive effects of RSV on liver carcinogenesis with decreased incidence [100, 101] and nodules number [100, 101] in animal models using chemical inducers [e.g., DEN [101] [102] [103] [104] , DEN plus phenobarbital [100] , and DEN plus 2-acetylaminofluorene (2-AAF)] [105] or using transgenic mice [e.g., hepatitis B virus X protein (HBV X)-expressing transgenic mouse] [106] , as well as the anti-tumor effects of RSV on xenograft models with hepatoma cell lines (e.g., AH-130 [107] , H22 [108, 109] , AH109A [110] , Bel-7402 [111] , and HepG2 [112] ) have been reported. The majority of studies showed that RSV reduced total tumor cell number [107] , tumor growth [108, 109] , tumor weight [110] , and angiogenesis/microvessel density [113] with rodent hepatoma Table 4 Lung cancer chemopreventive or anti-tumor effects of RSV in animal models (the entire period xenograft models, with decreases in cell cycle-related markers including cyclin B1 and p34cdc2 [109] , inflammatory IL-8 [111] , and angiogenesis-related vascular endothelial growth factor (VEGF) [113] , and an increase in the excretion of neutral sterols and bile acids into feces [110] . With chemically induced carcinogenesis models, RSV exerted apoptotic effects accompanied by the induction of proapoptotic markers (expression of Bax [100, 104] and p53 [104] , PARP cleavage [104] , caspase-3 activation [104] , cytochrome-c release [104] ) and antioxidant/detoxification regulator (Nrf2) [103] . On the other hand, RSV reduced an anti-apoptotic marker in the liver (expression of Bcl-2 [100, 104] ), inflammatory proteins in the liver (Hsp70 [114] , COX-2 [114] , nuclear NFκB [114] , cytosolic inhibitor of kappa B (IκB) [114] , TNF-α [102] , IL-1β [102] , IL-6 [102] , and iNOS [103] ), oxidative stress markers in the liver [thiobarbituric acid reactive substances (TBARS), protein carbonyls, 3-nitrotyrosine, and iNOS] [103] , and other factors both in the liver and serum [alkaline phosphatase (ALP), acid phosphatase (ACP), 5′-nucleotidase (5′ND), γ-glutamyl transpeptidase (γ-GT), and LDH] [104] , and a serum marker for liver cancer (α-fetoprotein) [104] .
In the spontaneously induced hepatocellular carcinoma in HBV Xassociated transgenic mice, RSV inhibited intracellular reactive oxygen species (ROS) and hepatic lipogenesis with the down-regulation of liver X receptor-α, sterol regulatory binding protein-1c, acetyl-CoA carboxylase (ACC), FAS and peroxisome proliferator-activated receptor γ (PPARγ). The expression of energy metabolism related proteins including 5′ AMP-activated protein kinase (AMPK) and Sirt1 was enhanced [106] .
Other cancers in recent years (2009-2014)
High levels of post-translational modification with O-linked β-Nacetylglucosamine (O-GlcNAc) moieties are a manifestation of tumor progression, and one feature of chronic lymphocytic leukemia cells [115] . RSV treatment increased survival rate and reduced tumor burden with decreased spleen weight and high levels of O-GlcNAc (a marker of tumor progression) proteins in the spleen of both friend murine leukemia virus-or CB3 cell line-engrafted mouse erythroleukemias [115] . RSV could prolong the lifespan of mice engrafted with acute myeloblastic leukemia cells Kasumi-1, with the attenuation of signal transducer and activator of transcription 3 (STAT3) phosphorylation [116] . However, intraperitoneal or dietary RSV did not attenuate the progression of high risk human acute lymphoblastic leukemia with translocation t(4;11) [t(4;11) ALL] in mice engrafted with t(4;11) ALL cells [54, 60] .
RSV application prevented the incidence and growth of oral preneoplastic lesions and oral squamous cell carcinoma in DMBAinduced oral carcinogenesis in the hamster cheek pouch [117] . RSV treatment reduced tumor growth of human nasopharyngeal carcinoma cells (CNE-2Z cell line) [118] , head and neck cancer-derived tumorinitiating cells (HNC-TICs) [119] , and head and neck squamous cell carcinoma (HNSCC) cells (FaDu cell line) [120] , in nude mouse xenograft models. With the anti-tumor effect of against head and neck cancer, RSV suppressed tumor stemness by reducing the expression of stemness markers (Oct4 and Nestin) and mesenchymal-like protein (Vimentin), and induced epithelial protein (E-cadherin) [119] , increased cleaved caspase-3 (an apoptotic marker) and γ-histone 2AX (a DNA damage marker) [120] .
RSV exerted anti-tumor and anti-angiogenic effects with decreases in microvessel density, plasma VEGF and intra-tumoral receptor type-2 (KDR/fetal liver kinase 1) levels with Ehrlich ascites carcinomabearing mice [121] . Intravesical instillation or RSV attenuated tumor growth with an increase in the expression of Sirt1 and p53, and a decrease in the expression of STAT3, p-STAT3, c-Myc, cyclin D1, survivin, and VEGF, in the orthotopic bladder transitional cell carcinoma (TCC) nude mouse model [122] . RSV inhibited tumor growth with a decrease in the expression of Ki67, cyclin D1, CDK4, and CDK6, and an increase in the expression of p21, p16, and β-Gal (a specific marker for mammalian senescent cells) in a gastric cancer xenograft nude mice model. The depletion of Sirt1 abolished the anti-tumor effect of RSV, demonstrating the involvement of Sirt1 in RSV action [123] .
The forkhead transcription factors of the O class (FOXO) are involved in oxidative stress signaling, proliferation, and tumorigenesis. RSV suppressed the tumor growth of PANC-1 cells orthotopically implanted in nude mice with increased apoptosis/cell cycle arrest proteins including Bim, cleaved caspase-3, and p27, and decreased cell survival/proliferation markers including the expression of PCNA and phosphorylation of ERK, PI3K, Akt, p-FOXO1 (Ser256), and FOXO3a (Ser253) [124] . However, RSV did not show an anti-tumor effect with NuTu-19 ovarian cancers in rats [125] , and one study demonstrated that RSV treatment did not affect tumor growth in the CWR22 xenograft model [37] .
Metastasis
Oral treatment of RSV via gavage or diet (0.1-1 mg/kg body weight/day) exhibited anti-metastatic effects with melanoma [33, 126] or breast cancer cells [127] in mouse models. In a hepatic melanoma model with B16M cells, IL-18 is mainly involved in metastases. Oral treatment with RSV inhibited metastatic growth, decreased metastatic foci and metastatic volume in the liver of intrasplenically injected B16M cells, with a decrease in proinflammatory IL-18 levels in hepatic blood [126] . Oral treatment with RSV reduced lung metastasis (decreased tumor volumes) of melanoma cells (B16BL6 cells) with the down-regulation of Akt expression [33] . RSV inhibited cancer metastasis with a decrease in the number of pulmonary nodules and plasma MMP-9 activity with 4T1 mouse breast cancer cell line-injected mice [127] .
In addition, in vitro treatment with RSV or via the intraperitoneal route resulted in suppression of metastasis. EMT has been linked to metastasis. Incubation with RSV inhibited LPS-induced EMT of K1735 melanoma cells in vitro, resulting in prolonged animal survival and reduced lung metastasis after tail vein injection of LPS-exposed K1735 cells in mice [128] . Intraperitoneal injection of RSV inhibited lung metastasis of A549/VC mice with a reduced number of colonies in the lung while the inhibitory effect was diminished in A549/FOXC2-injected mice, suggesting that FOXC2 is critical for RSV-mediated suppression of tumor metastasis [79] .
Inflammatory diseases
Over the past five years, studies involving RSV treatment in rodent models of inflammatory diseases have demonstrated downregulation of inflammation-induced biomarkers including proinflammatory mediators [e.g., IL-1β, -6, and -23p19, TNF-α, monocyte chemoattractant protein-1 (MCP-1), IFN-γ, NFκB, COX-2, iNOS, and prostaglandin E synthase-1 (PGES-1)], oxidative stress markers [e.g., MDA, nitric oxide (NO)], and endogenous vasoconstrictors (e.g., angiotensin II, and endothelin), and upregulation of inflammation-reduced biomarkers including anti-oxidant protein (e.g., SOD) and anti-inflammatory protein (e.g., IL-10).
RSV treatment attenuated histopathologic changes (saponification spots in the intraperitoneal cavity, severe pancreatic edema, hemorrhage, necrosis, etc.) as well as elevated biochemical markers in blood plasma (renin activity and levels of angiotensin II, endothelin, and NO) in taurocholate-induced severe acute pancreatitis (SAP) in rats [129] .
RSV reversed the decrease in SOD levels and the increase in MDA in intestine tissue. Also, RSV reversed the increase of TNF-α levels in serum. RSV prevented injury to the intestinal barrier in the rat SAP model [130] .
RSV decreased inflammatory cytokines (IL-1β, IL-6, TNF-α, and TGF-β1) and the histologic fibrosis score in cecal tissue of peptidoglycanpolysaccharide-injected rats (animal model for Crohn's disease) [131] .
RSV reduced cartilage destruction, the loss of matrix proteoglycan content in cartilage with a decrease in the apoptosis rate of chondrocyte and the level of NO in the synovial fluid in experimental osteoarthritis with rabbits [132] .
RSV treatment 1) extended survival with increased numbers of regulatory T cells and intestinal epithelial cell proliferation/ regeneration in the ileum mucosa, 2) decreased mucosal T lymphocyte and neutrophilic granulocyte numbers, 3) presented fewer proinflammatory enterobacteria and enterococci and higher anti-inflammatory lactobacilli and bifidobacteria loads, and 4) maintained intestinal barrier functions in a murine model of hyper-acute Th1-type ileitis following peroral infection with Toxoplasma gondii. This anti-inflammatory action accompanied an increase in anti-inflammatory cytokine IL-10 in ileum, mesenteric lymph nodes and spleen, and a decrease in proinflammatory cytokine expression (IL-6, IL-23p19, IFN-γ, TNF-α, and MCP-1) in the ileum [133] .
With chronic DSS-induced colitis in mice, RSV treatment resulted in a higher survival than control with reduced clinical symptoms including loss of body weight, diarrhea and rectal bleeding, and improved the disease activity index and inflammatory score. The anti-inflammatory effect of RSV was concomitant with decreased levels of TNF-α, IL-1β, PGES-1, COX-2 and iNOS, and p-p38, and increased levels of IL-10 [134] .
RSV treatment abrogated an increase in vascular permeability (increased peritoneal lavage) and neutrophil migration (in peritoneum) associated with a decreased release of serum IL-1β, IL-6, TNF-α, and macrophage inflammatory protein 1α (MIP)-1α in the C5 anaphylatoxin (C5a)-induced model of acute peritonitis [135] .
RSV treatment attenuated mechanical ventilation-induced upregulation of pulmonary NFκB activity but without alteration of other cytokines including IL-1β, IL-6, and keratinocyte-derived chemokine (KC) in the lung, and TNF-α, KC and, IL-6 in plasma [136] .
Finally, RSV treatment reduced the incidence and severity of collagen-induced arthritis in a mouse model [137] .
The summary of anti-inflammatory capacity of RSV in animal models is demonstrated in Table 7 .
Cardiovascular diseases
According to the WHO (http://www.who.int/cardiovascular_ diseases/about_cvd/en/), cardiovascular disease (CVD) includes disorders of the heart and blood vessels, including hypertension (high blood pressure), coronary heart disease (heart attack), cerebrovascular disease (stroke), peripheral vascular disease, heart failure, rheumatic heart disease, congenital heart disease, and cardiomyopathies. Rodent animal models have been frequently used to evaluate the therapeutic potential of drug candidates for the treatment of cardiovascular disease. However, various test agents selected from such animal studies have been found to be ineffective in clinical trials [138] . In terms of clinical relevance for the treatment of cardiovascular diseases, biological experimentation with pigs may offer an advantage over rodent studies, since there is a closer resemblance to the human in terms of anatomy, physiology, and genetics [139] . The effects of RSV on various cardiovascular diseases are summarized in Table 8 .
Restenosis
During vascular repair after re-vascularization or aortic injury, restenosis might occur with neointimal hyperplasia. In earlier studies, RSV treatment was shown to attenuate restenosis [140] [141] [142] with reduced neointimal hyperplasia [140] [141] [142] [143] [144] in artery injury models of rabbits [140] , rats [141, 143, 144] and mice [142] . In addition, RSV upregulated the expression of eNOS [141] [142] [143] , p-eNOS [143] , NO [142] , Sirt1 [143] , and p-AMPK [143] while it downregulated that of iNOS [143] , platelet endothelial cell adhesion molecule (PECAM) [143] , MMP-9 [143] , 8-iso-PGF2α [144] , MCP-1 [144] , and IL-6 [144] . More recently, it has been found that RSV treatment prevented restenosis with a reduction of neointimal hyperplasia in carotid artery-injured [142] [143] [144] and femoral wire-injured [143] models with rodents. The suppressive activity of RSV on neointimal hyperplasia was abolished in ER-α −/− mice [142] , endothelial NOS (eNOS) knockout mice [143] , and in N G -nitro-L-arginine methyl ester (L-NAME)-co-treated mice [142] or rats [143] , suggesting that RSV exerts the effect through ER-α-dependent NO production [142] .
With clinical signs of the protective effect of RSV on restenosis, RSV induced arterial NOS activity and NO production in carotid artery injured mice with high-fat diet [142] , and reduced inflammatory mediators including iNOS [143] , platelet/endothelial cell adhesion molecule [143] , MMP-9 [143] , 8-iso-PGF2α [144] , MCP-1 [144] and IL-6 [144] , and induced eNOS, p-eNOS, Sirt1, and p-AMPK in carotid arteryinjured rats [143] .
Hypertension
Several experimental models with animals have been employed to elucidate the effect of resveratrol on hypertension. Studies using spontaneously hypertensive rats (SHRs) [145] [146] [147] [148] [149] [150] [151] [152] showed that RSV treatment lowered systolic blood pressure (SBP) [145] , prevented the development of concentric hypertrophy [149] , reduced myocardial fibrosis [152] , and improved endothelium-dependent vascular relaxation in response to acetylcholine (Ach) [145, 147] and myocardial performance [148] .
Also, RSV reduced oxidative DNA damage [146] , glycoxidative stress [146] , and oxidative stress [148, 149, 152] . The molecular alterations by RSV in SHRs were observed in the heart with decreases in HNE-LKB1 adduct and p-p70S6K expression, and increases in p-LKB1 and p-AMPK [148] . In arteries of SHRs, ERK signal [150] , PCNA expression [150] , and p-p70 S6 kinase [151] were decreased, but protein kinase G (PKG) activity [150] and the expression levels of p-eNOS [151] , LKB1 [151] , and AMPK [151] were increased by RSV intervention.
More recently, it has been shown that RSV supplementation attenuated monocrotaline-induced pulmonary hypertension in rats, with a decrease in right ventricular systolic pressure, right ventricular hypertrophy, and medial thickening of intrapulmonary arteries. Also, RSV increased pulmonary artery atrogin-1 expression [153] .
RSV treatment improved survival without body weight loss, protected against cardiac and aortic endothelial dysfunction, and normalized reduced mitochondrial respiration, biogenesis, and mitochondrial fatty acid utilization. Related genes, including PPARα, carnitine palmitoyltransferase Ib (CPT-1b), and middle-chain acyl-CoA dehydrogenase, were normalized with RSV treatment in Dahl salt-sensitive rats fed a high-salt diet [154] .
RSV decreased mean arterial pressure and heart rate, diastolic and systolic blood pressure, superoxide levels in the rostral ventrolateral medulla, and serum estradiol, with adult-cycling female rats in which hypertension was induced by chronic exposure of estradiol-17β [155] . RSV did not affect blood pressure, placental and renal blood flows in desoxycorticosterone acetate-induced hypertension in pregnant rats (preeclampsia model) [156] .
RSV improved flow-mediated vasodilation, prevented increases in systolic blood pressure, reduced hypertrophic growth of the myocardium, decreased serum 4-HNE which is known to inhibit liver kinase B1 (LKB1) activity, together with increased phosphorylation of eNOS, LKB1, and AMPK, and reduced phosphorylation of p70 S6 kinase (prohypertrophic signaling) in mesenteric artery and ventricles in SHRs and angiotensin-II hypertensive mice (LKB1-AMPK-eNOS signaling axis) [151] .
RSV treatment reduced the systolic blood pressure in rats with fructose-induced hypertension, concomitant with a decrease in Table 7 Anti-inflammatory effects of RSV in animal models (2009) (2010) (2011) (2012) (2013) (2014) NADPH oxidase subunits (p67, p22-phox) and ROS, and an increase in NO and SOD2, p-AMPK, Akt, and neuronal NOS [157] .
Myocardial ischemia/infarction
RSV post-treatment increased survival and delayed the progression of cardiac remodeling with a reduced heart weight/body weight ratio, lung weight/body weight ratio, and old infarct size in a murine myocardial infarction model with global ischemia. In addition, RSV pretreatment decreased infarct size when ex vivo murine hearts were exposed to soluble fractalkine/chemokine (C-X3-C motif) ligand 1 (CX3CL1), which was reported to exacerbate heart failure [158] .
RSV pretreatment reversed the decrease in expression of adenylate kinase 1 and mitochondrial NADP + -dependent isocitrate dehydrogenase (known to increase myocardial energetic efficiency and reduce ROS-mediated damage) in surviving rats after permanent ligation of the left anterior descending artery under isoflurane anesthesia [159] .
RSV decreased the myocardial infarct area in ischemia-reperfusion induced myocardial infarction in rats [160] and pretreatment improved the recovery of post-ischemic ventricular functions, with decreases in myocardial lipoperoxidation, free iron, and CAT activity, and increases in peroxidase activity, expression of Fe-SOD and Mn-SOD in ischemia/ reperfusion (I/R)-induced injury with rats [161] .
RSV supplements prevented an increase in body mass index and blood glucose levels after dextrose infusion, and reversed the decrease in cardioprotective autophagy in chronically induced ischemic myocardium in pigs fed a high cholesterol diet, with normalization of increased p-mammalian target of rapamycin (mTOR), decreased p70-S6K, lysosome-associated membrane protein 2 (LAMP-2), and LC3A-II, to levels of pigs fed a regular diet [162] .
Although RSV supplement decreased body mass index, it did not significantly alter insulin signaling [AMPK, p-AMPK, insulin receptor substrate-2 (IRS2), p-IRS2, PI3K, Akt, p-Akt, FOXO1, p-FOXO1, glycogen synthase kinase 3β (GSK3β), p-GSK3β, PPARγ co-activator-1alpha (PGC-1α), glucose transporter 1 (GLUT1), and GLUT4] in chronically induced ischemic myocardium with pigs fed a high cholesterol diet [163] .
RSV supplements attenuated regional wall motion abnormalities in the ischemic area, increased myocardial blood flow, preserved endothelium-dependent coronary vessel function with an improved response to substance P, and decreased mean arterial blood pressure, diastolic blood pressure, and total cholesterol, in chronically induced ischemic myocardium with pigs fed a high cholesterol diet, concomitant with greater expression of VEGF (a potent vasodilator), p-eNOS (ser1177) (which is involved in the generation of NO, a vasorelaxant), NFκB (a transcription factor for VEGF), and p-Akt (Thr308) (pro-survival protein), in studies conducted with pigs fed a regular diet or a high cholesterol diet [164] .
With chronical ischemic myocardium in pigs fed a high cholesterol diet, supplemental RSV 1) lowered body mass index, and 2) improved each of the following: glucose tolerance with a decrease in blood glucose levels 30 min after dextrose infusion, endothelial function with an increase in microvascular relaxation response to ADP, and myocardial functions with decreases in systolic blood pressure, double product (pressure-rate product, indirect index of myocardial oxygen consumption), ventricular contractility assessment, and ventrical segmental shortening [165] . RSV treatment also decreased free fatty acids, cholesterol, insulin resistance, and C-reactive protein levels in serum. Notably, RSV treatment led to induction of the downstream molecules of Sirt1 including IRS1, GLUT1, and p-AMPK, and reduction of retinol binding protein 4 (RBP4), which inhibits glucose uptake and blocks insulin signaling, in chronically ischemic myocardium in pigs fed a high cholesterol diet [165] .
Atherosclerosis
Both short-term (24 days [166] and 14 weeks [167] ) with a higher dose (2 [166] and 11 [167] mg/kg/day) in rabbits [166] and mice [167] , and long-term (12 [168] [168] and 0.257 [169] mg/kg/day) of RSV in mini pigs displayed a protective effect on atherosclerosis.
RSV treatment resulted in milder aortic atherosclerotic lesions, a reduced intima area and intima/media layer area ratio, and decreased vascular cell adhesion molecule 1 (VCAM-1), MCP-1, and IL-6 in the descending aorta of rabbits with hypercholesterolemic diet-induced atherosclerosis [166] .
RSV treatment reduced the atherosclerotic lesion area of the aortic root, increased the collagen/macrophage ratio in atherosclerotic lesions (a marker of plaque stability) decreased plasma cholesterol levels, and improved macrophage function in APOE*3-Leiden.CETP (E3L.CETP) mice fed a cholesterol-rich diet [167] .
RSV treatment reduced collagens (COL1A, COL3A), lipoprotein lipase and fatty-acid binding proteins in peripheral blood mononuclear cells (PBMNC) of high-fat diet pigs [168] . RSV treatment moderately alleviated atherosclerosis by reducing lipid drops in the intima of the aorta, decreasing vascular oxidative stress (decreased superoxide anion), decreasing suppressor of cytokine signaling 1 (SOCS1) in male PBMNCs, and decreasing SOCS3, and increasing vinculin in female PBMNCs in pigs fed an atherogenic diet [169] .
Other cardioprotective effects
RSV pretreatment attenuated LPS-induced myocardial injury in mice (sepsis-related myocardial injury; septic cardiomyopathy), with decreased end diastolic left ventricular inner dimension, serum creatine kinase (CK) and LDH, as well as increased the ejection fraction. In addition, RSV inhibited the expression of proinflammatory mediators including TNF-α, IL-1β, MIP-1α, and MCP in heart tissue, while it induced the expression of HO-1 and glutamate-cysteine ligase regulated by Nrf2 activation [170] .
RSV pretreatment attenuated left ventricular remodeling and led to a recovery in exercise capacity, with a decrease in the expression of molecular markers of cardiac dysfunction (atrial natriuretic peptide), and oxidative stress (4-HNE), and an increase in the expression of mitochondrial function-related markers (mitochondrial electron transport chain complexes, and mitofusin-1 and -2) in a doxorubicin-induced mouse cardiac injury model [171] .
In a doxorubicin-induced rat cardiac injury model, RSV pretreatment attenuated a decrease in body and heart weights as well as an increase in left ventricular necrosis and fibrosis, reduced left ventricular lipid peroxidation, hydroxyproline, TNF-α, caspase-3 levels, and serum creatine kinase-myocardial band (CK-MB) activity, and restored left ventricular reduced glutathione content and SOD activity [172] .
RSV post-treatment attenuated cardiac hypertrophy with a decrease in abnormalities in cardiac structure and function in pressure overload rats induced by abdominal aortic banding surgery [173] .
RSV pretreatment normalized cardiac output and left ventricular performance (± dP/dt max ), with a decrease in DNA fragmentation (apoptosis), myeloperoxidase (MPO) activity, IL-6 levels, and intercellular adhesion molecule 1 (ICAM-1) levels, and an increase in p-Akt with cardiac tissues, with a trauma-hemorrhage and resuscitation model performed with rats [174] .
Other vascular protective effects
RSV pretreatment inhibited angiotensin II-induced arteriolar leukocyte adhesion in mesenteric arterioles, and leukocyte-endothelial cell interactions, in the postcapillary venules of rats [175] , and attenuated ovariectomy (animal model of estrogen deficiency)-induced 1) leukocyte adhesion to the arteriolar endothelium, 2) venular leukocyteendothelial cell interactions, 3) increase of circulating levels of CINC/ KC, MCP-1, and MIP-1α, and 4) upregulation of P-selectin and VCAM-1 in the arterial endothelium of rats [175] . Pretreatment also showed protective effects on abdominal aortic aneurysm in both CaCl 2 -induced mouse and elastase-induced rat models with a reduction in aneurysm expansion, inflammatory cell infiltration, and molecular markers related to inflammation, oxidative stress, matrix proteolysis, etc. [176, 177] .
RSV pretreatment attenuated the expansion of abdominal aortic aneurysm as judged by reduced aneurysm size (decrease in aortic diameter) and inflammatory cell infiltration in the aortic wall of mice. At the molecular level in the aortic wall, RSV decreased i) mRNA expression of MCP-1, TNF-α, ICAM-1, CD68, VEGF-A, p47, glutathione peroxidase 1 (GPx-1), and GPx-3, ii) 8-hydroxy-2′-deoxyguanosine (8-OHdG)-positive, Mac-2-positive, CD31-positive, and 4-HNE-positive cells, iii) the activities of MMP-2 and MMP-9, and iv) phosphorylation of p65 [176] . With abdominal aortic segments from the rat with abdominal aortic aneurysm [177] , RSV pretreatment decreased CD62L-monocyte subset expansion, CD143 monocyte expression, MMP-9 activity and TNF-α levels in plasma, and expression of MMP-9, VEGF, and TNF-α.
RSV supplementation displayed protective effects on high fat dietinduced endothelial dysfunction in Nrf2 wild type mice (Nrf2 +/+ ), with increased acetylcholine-induced vasodilations in skeletal muscle arterioles, decreased oxidative stress and apoptosis in branches of the femoral artery. The protective effects of RSV were partially abolished in Nrf2
−/− mice receiving a high fat diet, suggesting that the RSV effects are mediated by Nrf2 [178] . RSV treatment increased renal blood flow (RBF) and decreased renal vascular resistance in rats. However, upon L-NAME (a NOS inhibitor) and tempol (a SOD mimetic) pretreatment, but not indomethacin (a COX inhibitor) pretreatment, the increase in RBF by RSV was diminished, indicating that the renal vasodilatory effect of RSV is related to NO production and superoxide scavenging [179] .
RSV significantly accelerated re-endothelialization (decreasing the risk of thrombosis) in mice fed a high-fat diet with carotid artery injury [180] .
Finally, RSV treatment increased muscle microvascular blood volume at 30, 60, and 90 min, and muscle microvascular blood flow at 30 and 60 min. However, systemic pretreatment with L-NAME (NOS inhibitor) and TNF-α (known to induce ROS generation) neutralized the vasodilatory effect of RSV on muscle microvasculature, suggesting that the effect is exerted by increasing vasorelaxant NO as well as reducing TNF-α-induced ROS production [181] .
The effects of RSV on various cardiovascular diseases are summarized in Table 8 .
Diabetes
With diabetic animal models, more than half of the reported studies involved induction of diabetes by treatment with streptozotocin (STZ). STZ is used for the production of insulin-dependent (type I) diabetes mellitus via damage of pancreatic beta-cells that occurs within 48 h and lasts for up to 4 months [183] . In line with this, the duration of studies with RSV varied from 6 days to 4 months which fall into the abovementioned range. RSV administration ameliorated diabetic symptoms, including body weight loss, polyphagia, polydipsia, delayed onset of insulin resistance, and increased glucose uptake by hepatocytes, adipocytes, and skeletal muscle, and hepatic glycogen synthesis in diabetic rodents. Diabetes eventually can lead to the onset of complications including cardiomyopathy, nephropathy, neuropathy (e.g., autonomic neuropathy predisposing to gastroparesis and peripheral sensory neuropathy predisposing to foot ulcers), ketoacidosis, vasculopathy (e.g., retinal vasculopathy), hypertension, stroke, and hyperosmolar hyperglycemic nonketotic syndrome [184] . Treatment with resveratrol resulted in the alleviation/amelioration of diabetic complications with normalized/recovered clinical/biochemical markers in diabetic animal models, suggesting potential anti-diabetic activity. In the component of this review dealing with animals, only effects of RSV with the STZinduced model are described.
Although some studies have reported that RSV had no effect on blood glucose levels [185, 186] , the majority of publications show reduced blood glucose levels (hypoglycemic effect) [187] [188] [189] [190] [191] [192] . In fact, RSV delayed the onset of insulin resistance with increased glucose uptake by hepatocytes, adipocytes, and skeletal muscle, and increased hepatic glycogen synthesis in diabetic rodents [187] . In addition, RSV treatment resulted in a hypolipidemic effect with decreased plasma trigylcerides [187] .
Elevated levels of oxidative/nitrosative stress markers including i) MDA, xanthine oxidase (XO), and NO in the hippocampus, cortex, cerebellum, brain stem, and spinal cord [193] , ii) MDA in plasma/blood [190, 194, 195] , iii) peroxynitrite in plasma [194] , and iv) TBARS in the kidney [186] , were decreased by RSV treatment. The levels of Trx-1 [189] in the heart, and the activities of antioxidant enzyme including i) CAT in plasma/blood [194, 195] and sciatic nerve [194] , and ii) MnSOD in the heart [189] and SOD in the kidney [186] , were increased by RSV treatment. Additional alterations observed with STZinduced diabetic rats were also reversed by RSV intervention. RSV attenuated body weight loss [187] , and reduced the symptoms of nephropathy by inhibiting the increase in kidney weight/body weight ratio [186] , plasma creatinine level [186, 191] , blood urea nitrogen (BUN) [186] , and blood urea [191] .
RSV attenuated neuropathy, for instance, RSV reversed the STZinduced enhancement of contractile responses to noradrenaline (NA) [190] and the decrease in the relaxation response to acetylcholine (Ach) [190] . Also, RSV suppressed polyphagia [187] , polydipsia [187] , cold allodynia [196] , and hyperalgesia [194, 196, 197] , while it normalized decreased motor nerve conduction velocity (MNCV) and nerve blood flow (NBF) [194] .
RSV treatment decreased the enzyme activities of aspartate transaminase (AST), alanine transaminase (ALT), and ALP [191] in serum, and suppressed the expression levels of p38 and p53 in the kidney [186] , Cav-1 [192] in the heart, and p-Akt (S473) in the soleus muscle [188] . On the other hand, RSV increased p-AMPK [192] , p-Akt [189, 192] , p-eNOS [189, 192] , HO-1 [189] , GLUT-4 [192] , Cav-3 [192] , and VEGF [189] in the heart, and SIR2, p-histone H3 in the kidney [186] . In addition, treatment improved left ventricular function throughout reperfusion with decreased infarct size and cardiomyocyte apoptosis in the global ischemia model [189] .
Collectively, RSV ameliorated various diabetic symptoms and complications in STZ-induced diabetic animal models, with underlying molecular mechanisms including a reduction in oxidative/nitrosative stress and inflammation generated during high-glucose metabolism, and the induction in signaling pathways such as AMPK and Sirt.
Biomarkers altered by RSV in STZ-induced diabetic models are listed in Table 9 .
Effects of RSV on circulating/systemic biomarkers
Recent studies report that the unfavorable alterations observed in the circulatory and vascular systems of STZ-induced diabetic rodents were improved by treatment with RSV. This includes amelioration of deregulated biomarkers related to hyperglycemia, hyperlipidemia, oxidative stress, inflammation, liver dysfunction, and renal dysfunction in the blood/serum/plasma of diabetic rodents. RSV treatment reduced STZinduced hyperglycemia with 1) a decrease in blood/plasma glucose levels [187, [189] [190] [191] [192] 203, 207, 211, 222, 226, 228, 229] , plasma fructosamine (a glycated protein) [217] , serum advanced glycation end products [200] , and blood glycosylated hemoglobin (HbA1c) [211] , and 2) an increase in plasma insulin [191, 211] , adiponectin [200] and C-peptide [200] levels.
Oxidative or nitrosative stress-related markers, which were altered in STZ-induced diabetic rodents, were reversed by RSV treatment. RSV treatment reduced plasma lipid peroxidation [211, 222] with decreased levels of plasma MDA [190, 194, 195, 207] . Additional decreases in reactive oxygen/nitrogen levels including blood NO [211] , plasma Lipid raft fraction in left ventricle↑P [192] , kidney↑P/E [203] , hippocampus↑P [204] , liver↑A [205] Alanine aminotransferase (ALT), activity Serum↓ [206] , kidney↓ [200] , serum↓ [191, 201, 207 ] Aspartate aminotransferase (AST), activity Serum↓ [206] , kidney↓ [200] , serum↓ [191, 201, 207 ] Aminolevulinate dehydratase (δ-ALA-D), activity Liver↑ [206] , kidney↑ [206] AKT, phosphorylated Left ventricle↑ [192] , kidney↓ [208] , I/R left ventricular tissue↑ [189] and I/R heart↑ [209] Bilirubin Serum↓ [201, 207] Catalase, activity I/R brain↑ [210] liver↑ [201, 206] , kidney↑ [206] , sciatic nerve sections↑E [194] , blood↑ [202] , red cell↑ [195] [201, 206, 207, 226] , aortic tissue↑ [226] , kidney↑ [206] kidney↑ [214] , blood↑ [202, 222] , pancreas↑ [211] , corpora cavernosa↑ [218] (continued on next page)
peroxynitrite [194] , plasma superoxide anion [209] , plasma hydroperoxide [211] , and plasma protein carbonyl [211] were reported as a result of treatment, along with increases in plasma levels of antioxidants including reduced glutathione [211] , vitamin C [211] , vitamin E [211] , and ceruloplasmin [211] , as well as the activities of antioxidant enzymes in blood including GPx [202] , CAT [202] , and SOD [202, 222] . As mentioned above, hyperlipidemia, one of the diabetic complications, can be alleviated by RSV treatment [226] , and this is associated with a decrease in total cholesterol [206, 207, 220, 229] , triacylglycerol [206, 207, 220] , low-density lipoprotein (LDL) [207] , and total cholesterol to high-density lipoprotein (HDL) ratio [207] in serum.
RSV treatment attenuated diabetic inflammation, accompanied by downregulated expression levels of IL-1β [211, 220] , IL-6 [211, 220, 222] , NFκB [211] , and TNF-α [197, 211, 222] in serum or plasma.
Liver function damage caused by STZ can be inhibited by RSV treatment with modification of related biomarkers. RSV treatment reversed the elevated enzymatic activities of alanine aminotransferase (ALT) [191, 201, 206, 207] , aspartate aminotransferase (AST) [191, 201, 206, 207] , γ-glutamiltransferase (γ-GT) [206] , and ALP [191, 201] , and abolished the increased levels of bilirubin [201, 207] in serum.
In relation to nephropathy, RSV treatment ameliorated renal dysfunction as judged by lowering plasma creatinine [203] and blood urea nitrogen [203] .
Effects of RSV on blood vessels
RSV treatment inhibited STZ-induced vasculopathy [217] in rodents. RSV decreased i) vascular permeability in the aorta [217] , retina [217] , kidney [217] , and blood-brain barrier [204] , ii) vascular smooth muscle cell proliferation [217] , and iii) aortic collagen deposition/cross-linking [217] , whereas it normalized the impaired vascular reactivity/response (e.g., increased endothelium-dependent relaxation upon acetylcholine exposure in the aortic ring) [190, 226] . In addition, the expression levels of biomarkers in blood vessels of diabetic rodents were altered by RSV treatment. The expression levels of ICAM-1 [220] , MCP-1, chemokine (C-C motif) ligand 2 (CCL2) [220] , TNF-α [220] , and NFκB (total and nuclear) in the thoracic aorta and carotid artery [220] were downregulated. Also, the expression levels of PCNA [217] , p-ERK1/2 [217] , receptor for advanced glycation end product [217] , and nuclear NFκB [217] in aortic tissue were decreased. [210] , thoracic aorta and carotid artery↓ [220] , kidney↑ [203] , kidney↓ [200] , liver↓ [201] , hippocampus↓ [204] , serum↓ [197] , plasma↓ [ I/R brain↓ [210] , liver↓ [207, 226] , aortic tissue↓ [226] , plasma↓ [190, 194, 195, 207] , kidney↓ [214] , hippocampus, cortex, cerebellum, brain stem and spinal cord↓ [193] , corpora cavernosa↓ [218] Nitric oxide (NO) Kidney↓ [200] , liver↓ [201] , brain↓ [197] , hippocampus, cortex, cerebellum, brain stem and spinal cord↓ [193] 
Effects of RSV on the heart
Treatment with RSV can alleviate heart dysfunction (diabetic cardiomyopathy), one diabetic complication, accompanied with reversion of the expression or activity of biomarkers or biochemical parameters which are altered in STZ-induced dibetic rodents. RSV treatment lessened i) cardiomyocyte apoptosis with downregulation of autophagic flux [224] , ii) collagen deposition [225] , and iii) atrial cardiac stem/ progenitor cell loss [230] .
RSV treatment increased i) the expression of Sirt1 [215] , Rab7 (a crucial factor in the maturation of autophagosomes and their fusion with lysosomes) [224] , GLUT4 [192] , and caveolin-3 [192] , eNOS [209] , sarcoplasmic calcium ATPase 2a (SERCA2a; improves contractile dysfunction) [225] , and glutathione [212] , ii) enzymatic activities of pyruvate dehydrogenase [212] , GR [212] , and iii) phosphorylations of AMPK [192] , eNOS [192] , and Akt [192] were reverted to the normal condition with resveratrol treatment. Also, RSV decreased the expression of caveolin-1 [192] , p62 protein [224] , neuronal NOS (nNOS) [209] , iNOS [209] , the enzymatic activities of myocardial β-hydroxyacyl coenzyme-A dehydrogenase [212] , and citrate synthase [212] .
In addition, upon acute myocardial I/R injury, RSV treatment improved cardiac function upon I/R exposure, and decreased infarct size [189, 209] . The downregulated expression of cardiac p-Akt (Ser473) [189, 209] , p-eNOS [189] , thiredoxin-1 (Trx-1) [189] , HO-1 [189] , plasma NO, and the enzymatic activity of Mn-SOD [189] , and upregulated cardiac nitrotyrosine and plasma superoxide anion, were reversed by RSV treatment in diabetic rats [209] .
Effects of RSV on the kidney
RSV treatment ameliorated hyperglycemia-mediated renal dysfunction or diabetic nephropathy (e.g., oxidative damage [200] , microalbuminuria [213] /proteinuria [227, 228] , glomerular hypertrophy [213] , renal hypertrophy [228] , glomerulosclerosis [213] ), by lowering i) urinary levels of urea [206] , creatinine [206, 228] , albumin [213] , and albumin to creatinine ratio [208] , ii) kidney weight to body weight ratio [208] , iii) thickness of the glomerular basement membrane (GBM) [213] , and iv) vascular leakage (capillary permeability) [217] .
In renal tissue, RSV treatment attenuated increased levels of proinflammatory proteins including IL-1β [200, 203] , IL-6 [200, 203] , TNF-α [200, 203] , and NFκB [200, 208] . However, RSV did not significantly affect the expression of renal COX-1 and -2 genes in diabetic rats [216] .
RSV treatment might reduce renal tissue fibrosis, with the inhibition of TGF-β signaling by decreasing TGF-β [213] levels and the phosphorylation of smad2 [213] and smad3 [213] , and subsequent expression of extracellular matrix molecules (fibronectin [213] and type IV collagen [213] ) in diabetic glomeruli. Also, increased levels of fibronectin and type IV collagen in the renal cortex were decreased by RSV in STZinduced diabetic rats [214] . RSV decreased p-ERK1/2 [213] which is related to hypertrophy and extracellular matrix accumulation in the renal tissue of rodents.
RSV treatment had effects on carbohydrate metabolism-related enzymes in diabetic kidney, with inhibition of enzymatic activities of LDH [219] , glucose 6-phosphatase [219] , and fructose 1,6-bisphosphatase [219] , and induction of the enzymatic activities of hexokinase [219] , pyruvate kinase [219] , and glucose 6-phosphate dehydrogenase [219] .
RSV treatment alleviated oxidative stress in the STZ-induced diabetic kidney in rodents, as judged by induction of the expression of Nrf2 [200] , γ-glutamylcysteine synthetase heavy subunit [200] , glutathione S-transferase (GST), mu 3 [200] , and enhancing the enzymatic activities of CAT [200, 206, 214] , SOD [200, 206, 214] , GPx [200] , GST [200] , GR [200] , glyoxalase-I [200] and aminolevulinic acid dehydratase (δ-ALA-D) [206] . RSV also increased the levels of nonprotein thiols (liver/ renal), and vitamins C [200, 203] and E [200] , and reduced glutathione [200] , while it decreased the levels of superoxide anion [200, 203] , TBARS levels [206] , hydroxyl radical [200] , NO [200] , protein carbonyl [203] , and MDA [214] in diabetic kidney.
In relation to vascular complications in the diabetic renal cortex, RSV treatment reversed the increased expression of plasminogen activator inhibitor-1 (PAI-1) (fibrosis and thrombosis) [208] , intercellular adhesion molecule-1 (infiltration of leukocytes) [208] , and the p-Akt/Akt ratio [208] .
In relation to the glomerular filtration, RSV reversed the decrease of nephrin in the glomeruli of the diabetic kidney [213] . Also, in the diabetic kidney, RSV treatment enhanced the AMPK-Sirt1 pathway with upregulated expression levels of the p-AMPK [203] , AMPK [203] , Sirt1 [186, 214] , and FOXO1 [214] , and decreased expression levels of dephosphorylated histone H3 [186] and p53 [186] .
Effects of RSV on the hepatic system
RSV treatment resulted in the attenuation of liver dysfunction induced by STZ in rodent models. Treatment preserved the cellular function and structural integrity of hepatocytes from hyperglycemia-mediated oxidative damage [201] , and demonstrated antihyperglycemic potential with improved hepatic glycogen content [219] .
Treatment with RSV significantly decreased oxidative stress via i) reducing the levels of TBARS [206] , superoxide anion [221] , hepatic lipid peroxides [201] , hydroperoxides [201] , protein carbonyls [201] , MDA [221, 226] , protein carbonyl [221] , and NO [201] , and ii) increasing the levels of reduced glutathione [207] , vitamin C [201, 206] , vitamin E [201] , reduced glutathione [201] , nonprotein thiols [206] , hepatic glycogen [219] , Mn-SOD [221] , as well as increased the enzymatic activities of GST [201, 207] , GR [201] , NAD(P)H: quinone oxidoreductase (NQO) [207] , CAT [201, 206, 207] , SOD [201, 206, 207, 226 ], δ-ALA-D [206] , and GPx [201] .
RSV treatment decreased inflammation markers including TNF-α [201] , IL-1β [201, 221] , IL-6 [201] , and NFκB [201, 221] , and normalized liver function-related enzymes, including downregulation of the enzymatic activities of hepatic aspartate transaminase (AST) [201] , ALT [201] , and ALP [201] .
RSV attenuated STZ-induced alteration in carbohydrate metabolismrelated enzymes by i) reducing the activity of LDH [219] , glucose 6-phosphatase [219] , fructose 1,6-bisphosphatase [219] , glycogen phosphorylase [219] , and phosphoenolpyruvate carboxykinase [188] , and by ii) enhancing the activities of hexokinase [219] , pyruvate kinase [219] , glucose 6-phosphate dehydrogenase [219] , and glycogen synthase [219] in the liver.
RSV treatment normalized energy metabolism with increased expression of hepatic AMPK and Sirt1, and mitochondrial biogenesis [205] .
Effects of RSV on the central nervous system
Neurological complications or diabetic encephalopathy, including cognitive impairment with decreased hippocampal neurogenesis and synaptic plasticity, neuropathic pain, and cerebral infarction results from chronic hyperglycemia and subsequent oxidative stress. RSV treatment exhibited beneficial effects on diabetic brain with a decrease in neuropathic pain (thermal hyperalgesia [194, 196, 197] , cold allodynia [196] ), sensory neuropathy (e.g., thermal hypoalgesia with an increase in intraepidermal nerve fiber loss and the mean axonal diameter of myelinated axons of the tibial nerve [231] ), cerebral infarction upon I/R exposure [210] , neurodegeneration [204] (the reduction in motor nerve conduction velocity [194] , nerve blood flow [194] , DNA damage and apoptosis in sciatic nerve sections [194] ), memory impairment [199] , anxiety [232] , and neuroinflammation (astrocytic activation) [204] .
RSV decreased the apoptosis rate in the retina and sciatic nerve of diabetic rats [222] , and exhibited a cerebroprotective effect against cerebral infarction, as judged by reduced oxidative stress markers (MPO and MDA) and inflammatory markers (TNF-α and IL-6), and increased antioxidant (SOD and CAT) and anti-inflammatory markers (IL-10) in I/R-damaged brain tissue [210] . Inflammatory markers including TNF-α (hippocampus) [204, 210] , IL-6 (hippocampus) [204, 210] , and NFκB (hippocampus) [204] were inhibited, and Jak/Stat pathway-related genes including IL-15, IL-22, Socs2, and Socs5 [233] were suppressed. Treatment altered oxidative stress-related markers indicated by a decrease in NO release [193, 197] (hippocampus, cortex, cerebellum, brain stem and spinal cord), MDA [193] (hippocampus, cortex, cerebellum, brain stem and spinal cord), xanthine oxidase [193] (hippocampus, cortex, cerebellum, brain stem and spinal cord), and an increase in CAT (sciatic nerve sections) [194] .
RSV treatment reversed the expression levels of genes related to neurogenesis, neurotransmission, and synaptic plasticity: RSV upregulated Hdac4 and Wnt7a, while it down-regulated Hat1 and ApoE. RSV treatment inhibited the enzymatic activities of acetylcholinesterase (cerebral cortex synaptosomes [198] hippocampus [199] , cerebral cortex [199] , striatum [199] ). RSV improved energy metabolism/mitochondrial biogenesis with an increase in the activity of AMP-activated protein kinase (metabolic regulator that promotes insulin sensitivity and energy production) and mitochondrial number per neuron (hippocampus) [204] .
In addition, treatment improved cerebrovascular dysfunction. Blood vessel permeability [204] was decreased, and the responses/reactivity/ dilation of pial arterioles in response to ADP (eNOS-dependent agonist) and N-methyl-D-aspartic acid (nNOS dependent agonist) [223] was increased with diabetic rats.
Effects of RSV on the pancreas
Although there is a report that RSV treatment had no beneficial effect on glucose tolerance or graft survival on mouse islet engraftment [234] . RSV treatment protected beta cells from oxidative damage while maintaining their function and structural integrity [211] . In relation to the oxidative stress, the increased levels of lipid peroxides, hydroperoxides, and protein carbonyls and the decreased activities of SOD, CAT, GPx, and GST in diabetic pancreatic tissues were reversed by RSV treatment [211] . RSV treatment prevented apoptosis with decreased levels of cleaved forms of caspase-3 and PARP in the beta cells of the pancreas [235] .
Effects of RSV on spleen
RSV treatment alleviated oxidative stress correlated with the downregulated levels of superoxide anion content, protein carbonyl, and Mn-SOD in STZ-induced diabetic spleen. However, RSV treatment showed different effects on proinflammatory markers: RSV treatment decreased NFκB and IL-1β, whereas it increased TNF-α and IL-6 [221] .
Effects of RSV on the reproductive system
RSV treatment improved/restored erectile function with increases in the intracavernous pressure to mean arterial pressure ratio [236] , smooth muscle to collagen ratio in cavernosum tissue [218] , and smooth muscle content of the cavernosum [218] of STZ-induced diabetic rats. Also, deregulated biomarkers in the corpora cavernosa were normalized by RSV treatment. For instance, Sirt1 expression and SOD activity were upregulated, whereas the expression of apoptotic p53 and oxidative stress-related FOXO3a was downregulated [236] .
Effects of RSV on muscle/tendon
The reduced phosphorylation of Akt and GSK3 in both fast-and slow-twitch muscles in diabetes was reversed by RSV treatment [237] . RSV treatment improved the process of tendon healing with a higher ratio of newly synthesized collagen area to the healing region area [238] .
Effects of RSV on embryonic development
RSV suppressed diabetes-induced impairment during embryonic development, along with reversal of decreased expression of retinoic acid receptors, retinoid X receptors, and p-ERK1/2, and increased expression of p-c-Jun N-terminal kinase (JNK) and p-p38 [239] .
Obesity
With animal models, obesity is induced by providing high-caloric diet (e.g., excessive amount of dietary fat or sugar). Common markers for obesity include body weight and fasting serum levels of glucose and insulin. Of 13 studies [168, [240] [241] [242] [243] [244] [245] [246] [247] [248] [249] [250] [251] , 11 [168, [240] [241] [242] [243] [244] 246, [248] [249] [250] [251] include a standard diet control. Among ten studies [168, [240] [241] [242] [243] [244] [248] [249] [250] [251] which provide the body weight of animals, eight with rat or swine models showed significant differences between standard diet and obesity-inducing diet [168, 248] . Notably, RSV treatment is reported to reduce body weight [240, 241, 244, 249] or have no effect [242, 243, 250, 251] . Eight [240] [241] [242] [243] [244] 246, 250, 251 ] out of the abovementioned 11 studies [168, [240] [241] [242] [243] [244] 246, [248] [249] [250] [251] demonstrated that there is a significant difference in glucose tolerance between standard diet and fat/sugarenriched diet controls. All eight studies [240] [241] [242] [243] [244] 246, 250, 251] demonstrated that RSV regimens (dose range: 30-400 mg/kg body weight/ day, duration: 1-20 weeks) improved glucose tolerance [240, 242, 243, 246, 250, 251] or lowered fasting glucose level [241, 244] compared with obese controls with mice or swine models. Among the eight studies [240] [241] [242] [243] [244] [248] [249] [250] providing fasting insulin levels in blood/serum, six studies [240] [241] [242] [243] [244] 250] showed that treatment with RSV decreased circulating insulin in obese models using mice or pigs. However, a significant difference between a standard diet and a high-fat, high-sugar obese model in Rhesus monkeys was not detected [248, 249] .
A summary of the results from animal studies related to obesity is presented in Table 10 . As illustrated by the trend analysis shown in Fig. 3 , based on 13 reports in the literature, there is a tendency for RSV to improve glucose tolerance and decrease serum insulin, whereas alteration of body weight varies.
Central or peripheral nervous system diseases/disorders
In earlier studies (pre-2009), the neuroprotective properties of RSV with various stimuli have been reported. Neurotoxicity induced by kainic acid (excitotoxin) was alleviated by RSV treatment as judged by recovery of glutamate decarboxylase (GAD) activity in olfactory cortex and hippocampus [252] , reduction in incidence of convulsions along with brain MDA levels [253] , attenuation of hippocampal neuronal damage [254] , and a decrease in activation of astrocytes and microglial cells [254] in rats. In middle cerebral artery (MCA) occlusion-induced cerebral ischemia models, RSV reduced the total volume of infarction [255] [256] [257] [258] , suppressed motor impairment [256] , improved necrotic changes in the cortex and basal ganglia [259] , ameliorated the neurological deficit [258] , and decreased permeability of the blood-brain barrier [258] . RSV decreased levels of MDA [256, 260] , reduced glutathione [256] , MMP-9 in brain [259] , TNF-α, and MPO activity [258] , while it increased MMP-2 and VEGF [261] . Notably, RSV failed to protect the brain in PPARα knockout mice [257] , suggesting that the neuroprotective mechanism of RSV is related to PPARα.
Effect of RSV on depression
According to a fact sheet from the World Health Organization (WHO) in 2012, depression is a common worldwide mental disorder with more than 350 million patients (http://www.who.int/ mediacentre/factsheets/fs369/en/). To evaluate the antidepressant [242] potential of compounds using animal models, multiple approaches have been adopted including behavioral tests and biochemical/neurochemical assays. In behavioral tests, the clinical symptoms/signs of depression including anhedonia (incapability to perform rewarded behaviors) and helpless behaviors can be measured/quantified using a sucrose preference test, forced swim test, tail suspension test, and shuttle box test (learned helplessness model) [262] . In relation to pharmacological aspects, it has been reported that monoamine deficiency, alteration/ abnormality/dysfunction in hypothalamic-pituitary-adrenal (HPA) axis, reduction in neurogenetic/neurotrophic-growth factor, and dysregulation in the brain immune system are observed in depression models [263] . RSV was reported to exert antidepressant-like effects through alleviating depression-like symptoms/behaviors in rodent animal models. RSV treatment improved the helplessness symptom as judged by reducing the duration of immobility in the tail suspension or forced swimming tests in rats [264] and mice [265, 266] . Also, under chronic stress conditions, an increase in immobility time in both forced swim and tail suspension tests [267] , a decrease in sucrose preference [268] , the learned helplessness using the shuttle box method [268] , and an increase in adrenal gland/body weight [268] , were reversed by RSV treatment in rats.
In addition, RSV treatment altered molecular markers related to depression. RSV induced brain-derived neurotrophic factor (BDNF) levels in the hippocampus of unstressed rats [264] and mice [269] , as well as reversed the reduced expression of BDNF in the prefrontal cortex and hippocampus of chronic mild stress-exposed rats [270] . In addition, the reduced phosphorylation levels of cAMP response element-binding protein (CREB) and ERK, which is involved in learning, memory, and neuroplasticity, were normalized by RSV in stressed rats [270] .
RSV can regulate the monoaminergic system. In the chronic stress rat model, RSV attenuated the decrease in serotonin (hippocampus, frontal cortex, hypothalamus), noradrenaline (hippocampus, frontal cortex, striatum, hypothalamus), and dopamine (frontal cortex), and the increase in monoamine oxidase-A (MAO-A) activity (hippocampus, frontal cortex) [268] . These effects also were found in the normal condition of mice: the levels of serotonin (hippocampus, frontal cortex, hypothalamus), noradrenaline (hippocampus, frontal cortex), and dopamine (frontal cortex) were increased while the activities of MAO-A and MAO-B (hippocampus, frontal cortex) were decreased [266] . In addition, it was shown that the anti-immobility effect of RSV was abolished by pretreatment with the serotonin antagonist para-chlorophenylalanine, demonstrating the possible involvement of RSV on the serotonergic system as related to its antidepressant potential [266] .
As mentioned above, hyperactivity of the HPA axis along with upregulated corticosterone in serum was observed in animal models for depression. RSV reduced the upregulated serum concentration of corticosterone, which is known to increase during stress in chronically stressed-rats [267, 270] , as well as decreased serum corticosterone in unstressed mice [269] .
Effect of RSV on epilepsy/seizure
Epilepsy affects about 50 million people worldwide. Reagents including kainite and pentylenetetrazole (PTZ) have been used to induce epileptic seizures in experimental animal models [271] . RSV reversed biomarkers that are altered in epileptic rat models. S100 calcium binding protein B that is mainly produced by astrocytes and released into serum and cerebral spinal fluid is a useful biochemical marker to evaluate brain damage after seizure [272] . RSV normalized the increase of brain damage markers in epileptic models. RSV reduced S100B protein levels in the cerebral spinal fluid and serum [272] , neuron specific enolase levels in serum [273] , and the expression of caspase-3 (an apoptosis marker) [273] and kainate receptor of the hippocampus [274] with PTZ-induced epileptic rats. Indeed, histological observations demonstrated a protective effect of RSV on damage in CA1 [273, 274] , hilus [273] , or CA3a [274] of the hippocampus. In addition, altered oxidative stress parameters including increased MDA levels, reduced glutathione levels and CAT activity in epileptic brain of rats were reversed by RSV treatment [273] . Treatment with RSV increased seizure latency (delayed the onset of seizure) [272] and decreased seizure score [273] .
The Morris water maze is used to measure the location memory ability (spatial probe test), and spatial learning and memory ability (place navigation test) [272] . RSV affected behavioral changes in epileptic rats. Treatment led to recovery of impairment in location memory ability [272] and spatial learning and memory ability [272] , and decreased the number and rate of spontaneous seizures measured using 3 . Effects of RSV on glucose tolerance, serum insulin levels, and body weight with animal models used for studying obesity.
electroencephalography [274] in epileptic rats. However, RSV did not demonstrate protective effects on juvenile epileptic rats [275] .
Effect of RSV on Alzheimer's disease
Alzheimer's disease (AD) is characterized by intraneuronal β-amyloid (Aβ) plaques and hyperphosphorylated tau, leading to neuronal cell death and progressive memory loss. RSV reduces cognitive impairment and has a neuroprotective role, decreasing the amyloid burden and reducing tau hyperphosphorylation [276] .
RSV increased the mean life expectancy and maximal lifespan in SAMP8 (accelerated aging, a mouse model of sporadic and age-related AD) as well as their controls, the related strain SAMR1 [276] . RSV supplements (or RSV-fed animals) increased Sirt1 expression and consequent downregulation of apoptotic protein p53 in the cortex and hippocampus. Also, RSV supplements increased p-AMPK in the cortex and total AMPK in the hippocampus [276] .
RSV affected AD-related markers. The expression of a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10; possessing α-secretase activity) was increased and the expression of p-tau (Ser396) was decreased by RSV in the cortex and hippocampus. CDK5 protein levels and the p25/p35 ratio were decreased and p-GSK3β (Ser9) was increased in the cortex, but not in the hippocampus. Levels of Aβ plaques in the hippocampus were decreased in this mouse model [276] .
However, another study demonstrated that RSV neither improved cognitive function nor increased the expression of Sirt1 and acetylated p53 in the same mouse model [277] . This might be due to differences between the two studies, including the starting point of diet, duration, and dosage of RSV (e.g., starting at month 2 with 1 g/kg body weight for 7 months of treatment vs. starting at month 5 with 0.12 g/kg body weight for 2 months of treatment).
Aβ plaques are one of the unique features of AD. In animal models, AD can be induced by the administration of Aβ peptide accompanied by upregulation of iNOS and induction of HO-1 and neuronal apoptosis [278] . RSV improved spatial memory (decreased escape latency in the Morris water maze) with decreased accumulation of Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and lipid peroxidation in the hippocampus. The biomarkers iNOS and HO-1, altered in Aβ-induced AD mice, were normalized by RSV [278] .
Also, amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic mice expressing a chimeric mouse/human APP, mutant human PS1, are frequently used for AD studies. Both early (starting at 15 weeks of age) [279] and late (at 50-53 weeks of age) [280] administration of RSV in APP/PS1 mice demonstrated the therapeutic potential of RSV as judged by altered biomarkers. Dietary RSV increased the expression of ACC [279] , drebrin [280] , and transthyretin [280] , as well as the phosphorylation of AMPK [279] , GSK3β (Ser9) [280] , and tau (Ser396, Ser404) [280] . However, the effect on amyloid deposition differed from previous work, possibly due to the different starting points of diet, dosage, and duration.
Effect of RSV on Huntington's disease
Huntington's disease (HD) is caused by the mutation in huntingtin (htt) gene with clinical symptoms of involuntary hyperkinetic movements. HD models can be established in animals by toxins via inducing cell death either using excitotoxic agents including quinolinic acid and kainic acid, or disrupting mitochondrial machinery with 3-nitropropionic acid. Genetic models include transgenic mice such as R6/2, R6/1, N171-82Q, and YAC, or knock-in mice including HdhQ92, HdhQ111, CAG140, and CAG15O [281] .
Sirtuins are NAD-dependent deacetylases that regulate important biologic processes including transcription, cell survival and metabolism. Activation of Sirt1, a mammalian sirtuin, extends longevity and increases neuronal survival. An important substrate of Sirt1 is PGC-1α, a principal regulator of energy metabolism, whose function is significantly impaired in HD [282] . Administration of RSV (SRT501-M) increased expression of PGC-1α, as well as its downstream targets, nuclear respiratory factor-1 and uncoupling protein-1, in brown adipose tissue with the N171-82Q transgenic mouse model of HD [282] .
Effect of RSV on Parkinson's disease
Parkinson's disease (PD) is a neurodegenerative disease that affects about 1% of the population over 55 years of age. Animal models of PD can be classified into neurotoxic [6-hydroxydopamine, 1-methyl-1,2,3,6-tetrahydropiridine (MPTP), paraquat, rotenone], and genetically mutated animal models (mutations in the genes encoding α-synuclein and LRRK2, PINK1/Parkin, or DJ-1) [283] . Oxidative stress is a hallmark in the pathogenesis of Parkinson disease (PD), which involves the selective loss of nigral dopaminergic neurons.
In one study, RSV protected dopaminergic neurons against MPTPinduced cell degeneration almost to the same extent as PGC-1α overexpression [284] . RSV treatment demonstrated behavioral improvements in PD animal models. RSV decreased abnormal rotational behavior in rats [285, 286] and increased motor coordination skills in 6-hydroxydopamine-treated rats [287] and HtrA2 KO mice [288] .
RSV showed neuroprotective effects in dopaminergic neurons with an increased number of tyrosine hydroxylase (TH)-positive cells in striatum and substantia nigra pars compacta in MPTP-treated mice [284] and in the nigral area of 6-hydroxydopamine-treated rats [285, 286] along with an increase in dopamine and 3,4-dihydroxyphenylacetic acid levels in striatum [287] and nigrostriatum [289] . RSV increased the antioxidant activities in 6-hydroxydopamine-treated rats [286, 287] . TH is a rate-limiting enzyme in the synthesis of dopamine and is only present in dopaminergic neurons of the nigra area.
Effect of RSV on memory function
RSV treatment has been reported to improve memory in behavioral tests. Memory enhancement by RSV was blocked in Sirt1 mutant mice, suggesting that RSV improves memory via a Sirt1-dependent pathway [290] .
Intraventricularlly-injected RSV ameliorated long-term memory formation and LTP induction from hippocampus CA1 in 8-9 monthold mice [290] , and dietary treatment preserved cognitive function in aging mice with an improved cerebrovascular condition (higher microvascular density and a lower number of microvascular abnormalities), and had no effect on cholinergic cell number or fiber density [291] .
A protective effect of RSV against chronic alcohol-induced cognitive dysfunction/deficits, and impaired learning and memory in both adults [292] and neonatal [293] rats, was reported to improved cognitive performance (spatial memory) in homocysteine-induced oxidative stress, apoptosis and cognitive impairment [294] . With the senescenceaccelerated mouse (SAM), improved learning and memory ability, neuromuscular coordination, and sensorimotor capacity were reported [295] .
RSV treatment has also be invested in the following systems: i) Prevention of memory decline in ovariectomized (OVX) rats chronically treated with D-galactose (D-gal) [296] , ii) decreases in abnormality of pyramidal cells in the hippocampal CA1 sub-region in OVX rats chronically treated with D-gal [296] , iii) prevention of CA1 cell injury and improved cognitive deficits in ischemia-exposed rats [297] , iv) amelioration of impaired spatial learning and memory in hypoxiaischemia-exposed neonatal rats [298] , v) improved effects on learning and memory by acting on muscarinic cholinergic receptors in scopolamine-and mecamylamine-induced memory impaired rats [299] , and vi) increases in spontaneous locomotor activity, working memory, and spatial memory performance in non-human primates, mouse lemurs (Microcebus murinus) [300] .
Along with memory improvement, RSV treatment altered biochemical/molecular deficits. Reports have appeared indicating i) decreased acetylation levels of PGC-1α in mouse hippocampus [290] , ii) reduced acetylcholinesterase activity [292] , iii) reduced levels of lipid peroxidation, nitrite, TNF-α, IL-1β, nuclear NFκB p65, and caspase-3 [292] , iv) recovery of reduced glutathione [292] , v) increased SOD [292] and CAT activities [292] in the cerebral cortex and hippocampus of chronic ethanol-administered adult [292] and neonatal rats [293] , vi) reduced total homocysteine in plasma, reduced lipid peroxidase activity, DNA fragmentation, p53 expression in the hippocampus in homocysteine (which is known to cause apoptosis and impairment of neural plasticity in brain)-induced oxidative stress, apoptosis and cognitive impairment in rats [294] , vii) increased gene expression and activity of SOD, and activity of GPx in the brain of SAM [295] and in the serum of OVX rats chronically treated with D-gal [296] , viii) decreased MDA levels in the brain of SAM [295] , and ix) decreased TBARS levels in the serum and hippocampus in OVX rats chronically treated with Dgal [296] .
One study showed a negative effect of RSV in hippocampusdependent spatial learning and memory with reduction of p-CREB and BDNF levels in the hippocampus [301] .
Effect of RSV on ocular damage
RSV supplementation attenuated an increase in the expression of Bcl-2 and VEGF in the retina of neonatal rats with oxygen-induced retinopathy of prematurity [302] . Supplementation also shown to exert protective effects by inhibiting pathological parameters including TUNEL-positive retinal cells, outer nuclear layer thinning, and electroretinography changes in mice with light exposure (5000-lux white light for 3 h)-induced retinal degeneration. RSV reduced the activation of activator protein-1 and augmented Sirt1 activity in the retina [303] . RSV reduced the expression of eNOS and nNOS in an oxygen-induced (hyperoxia) retinopathy model with rats [304] .
RSV treatment attenuated decreased electroretinogram (ERG) bwave amplitudes, a loss of choline acetyltransferase indexing cholinergic amacrine cells, and increased vimentin levels (a marker of Müller cells), together with inhibition of upregulated MMP-9, HO-1, and iNOS, and recovery of downregulated Thy-1 (a marker of the neuron retinal ganglion cells) in high intraocular pressure-induced retinal ischemia with rats [305] .
RSV treatment ameliorated impaired retinal function with increased ERG a-and b-wave amplitudes, ischemia-mediated thinning of the whole retina and, in particular, the inner retinal layers with a retinal ischemic injury model induced by elevation of intraocular pressure in the rat [306] .
RSV inhibits tunicamycin (ER stress inducer)-induced vascular degeneration in the retina, together with inhibition of ER stress [downregulation of C/EBP homologous protein (CHOP), inositol-requiring enzyme-1α (IRE1α), Bip]. In addition, RSV inhibits retinal I/R-induced vascular degeneration, retinal I/R-induced upregulation of eukaryotic translational initiation factor 2α (eIF2α)-CHOP branch of ER stress, upregulation of IRE1α and Xbp1 splicing, and overexpression of Bip [307] .
RSV prevented a cigarette smoke-induced increase in choroidal neovascularization following laser injury [308] .
At the doses tested, no RSV effect was observed with the corneal neovascularization experimental model of corneal alkali burn in white Vienna rabbits [309] .
Effect of RSV on nociceptive pain
RSV exhibited analgesic/antinociceptive effects in several animal models. RSV treatment prevented the licking behavior in acute nociception models induced by capsaicin or glutamate with mice. Interestingly, RSV downregulated capsaicin-induced c-Fos and COX-2 expression in the spinal cord and COX-2 expression in the cortex [310] . Treatment reduced IL-6 or plantar incision-induced allodynia in the mouse paw, and prevented the transition of allodynia to a chronic pain state (persistent noniceptive sensitization induced by PGE 2 ) in mouse paws [311] .
RSV treatment attenuated mechanical allodynia and thermal hyperalgesia, with increased Sirt1 and decreased acetyl-histone H3 expression in the spine in rats subjected to a neuropathic pain model of chronic constriction injury (CCI) [312] . Spinal Sirt1 expression and deacetylase activity decrease after CCI surgery. RSV pretreatment alleviated CCI-induced neuropathic pain in mice, associated with thermal hyperalgesia and mechanical allodynia, which was reversed by intrathecal injection of the Sirt1 inhibitor EX-527, suggesting that the analgesic effect of RSV is mediated by Sirt1 deacetylase activity [313] .
RSV pretreatment resulted in an antinociceptive effect of long-term morphine infusion induced antinociceptive/morphine tolerance in rats, associated with reversal of the upregulated N-methyl-D-aspartate receptor subunit NR1 and NR2B subunits in the synaptosome fraction and the postsynaptic density-95/NR1/NR2B complex in spinal cords. RSV pretreatment suppressed proinflammatory cytokines (IL-1β, IL-6, and TNF-α) in spinal cords [314] .
Effect of RSV on other neuronal damage
RSV treatment resulted in varying neuroprotective outcomes with different study models involving neonatal rodents. RSV treatment did not prevent sevoflurane anesthesia-induced neuroapoptosis in neonatal mouse (six-day-old mice) brain [315] . However, prenatal RSV treatment alleviated early and late gestational stress-induced cognitive deficits/dysfunction in rats on postnatal day 40, without affecting reduced cerebral Na + , K + -ATPase activity which is related to memory consolidation [316] .
RSV pretreatment to postnatal day 7 rat pups resulted in neuroprotection against ethanol-induced cerebellar toxicity/damage with an increase in the survival of cerebellar granule cells, a decrease in apoptotic events such as cleaved caspase-3 protein levels and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, and a decrease in oxidative stress accompanied by increased levels of glutathione, nuclear Nrf2, QR1, and SOD2, and decreased levels of total thiol, MDA, and 8-iso-PGF2α (an oxidative stress marker for nonenzymatic lipid peroxidation) in the cerebellum [317] .
In an experimental model of hypoxic-ischemic encephalopathy with postnatal day 7 rat pups, RSV treatment normalized the performances in righting reflex, rotarod and water maze tests with a reduction of infarct and preservation of myelination [298] .
Chronic treatment of RSV attenuated disease onset and extended survival of transgenic mice overexpressing G93A-SOD1 (mutant SOD, a model of amyotrophic lateral sclerosis), with an increase in surviving motor neurons, levels of Hsp25 and Hsp70, and a decrease in acetylated heat shock factor 1 (HSF1) levels in spinal cords, demonstrating that the protective effect of RSV is mediated by Sirt1 with the deacetylation of HSF1 and subsequent upregulation of Hsps [318] .
RSV exerted motor neuron protective activity. RSV abated fluphenazine-induced intensity of vacuous chewing movements, and attenuated the reduction in both locomotor and exploratory activities in an animal model of orofacial dyskinesia [319] .
RSV exerted protective activity against neurodegenerative disorders. RSV treatment reduced the levels of CD4 + T-helper 17 (T H 17) cells (by inhibiting the differentiation of CD4 + T lymphocytes to IL-17A-positive T H 17 cells), IL-17A and MMP-2, -3, and 9, and elevated the levels of tight junction proteins (occludin and claudin-5) which improved Basso Beattle Bresnahan locomotor rating scale integrity in Ppt1-KO mice that mimic infantile neuronal ceroid lipofuscinosis [320] . RSV treatment i) alleviated fatigue symptoms with an increase in daily running activity, neurogenesis, and hippocampal BDNF expression, and a decrease in hippocampus atrophy, neuronal apoptosis, and hippocampal acetylated p53 expression in the fatigue mouse induced by Brucella abortus antigen [321] , ii) resulted in unfavorable effects on hippocampal neurogenesis and cognitive function; RSV impaired hippocampus-dependent spatial learning and memory, reduced the proliferation and survival of neural progenitor cells in the dentate gyrus of the hippocampus, associated with the elevated active form of AMPK, and the reduced p-CREB and BDNF in the hippocampus [301] , iii) improved rat dorsal neuronal function with increased Basso Beattle Bresnahan locomotor rating scale scores, restored neural morphology, increased the number of neurons, increased SOD activity and Bcl-2 expression, and decreased MDA, IL-1β, IL-10, TNF-α, MPO, apoptosis (TUNEL-positive cells, Bax, and caspase-3) in of spinal cord injured rats [322] , iv) elevated BDNF in the hippocampal tissues of rats [323] , and v) reduced infarct volumes during the acute phase of ischemic stroke reducing brain injury in mice, with suppressed expression of IL-1β and TNF-α, microglial activation, and ROS production in the ischemic cortex (neuroprotective) [324] .
RSV pretreatment prevented membrane lipid loss via reduction in the total content of gangliosides, phospholipids, and cholesterol in the hippocampi and cerebral cortex induced by global cerebral ischemia (ischemia/reperfusion injury) in rats [325] . Pretreatment also inhibited neuronal death, generation of ROS, lipid peroxidation and NO content while it improved oxidative stress parameters (decreased SOD and GPx, and increased CAT in the hippocampus; decreased SOD and the increased CAT in the cortex), and Na + , K + -ATPase (susceptible to free radical attacks, decreased after cerebral ischemia and in various chronic neurodegenerative disorders) activity in the cortex and hippocampus of rats with global cerebral ischemia [326] .
RSV treatment reduced ischemic cell death in the first ischemic insult (mild stroke) and in the recurrent insult (recurrent stroke). Blood-brain barrier disruption and edema followed recurrent stroke [327] .
Aging
Although it is controversial, some papers have indicated that RSV treatment can be beneficial for extending lifespan, reduce the aging process by inhibiting skin photoaging [38] caused by UV-B exposure, increase insulin sensitivity in old mice [328] , maintain T-cell compartment and suppress proinflammatory markers in aging-hybrid mice [329] , preserve mitochondrial function upon high-fat diet [330] , enhance telomere length and telomerase activity in the aorta [331] , improve aerobic performance and exercise capacity [331] , and decrease oxidative stress/damage in the liver and skeletal muscle [332, 333] .
Topical application of RSV reduced hyperpigmentation (or suppressed melanin) in UV-B-stimulated guinea pig skin, with a reduction in skin tyrosinase-related protein 2 which is necessary for melanogenesis, supporting RSV as a potential depigmentation agent for treating hyperpigmentation and skin photoaging [38] .
RSV treatment did not increase survival rates in old mice fed either standard diet or high-protein diet. Instead, RSV ameliorated insulin sensitivity in old mice fed standard diet with a decrease in resistin levels. However, RSV exhibited dual effects with an increase in serum inflammatory markers (CXCL1, and CCL5) and superoxide production and with a decrease in aortic distensibility in old mice fed high-protein diet [328] .
RSV preserved the CD4 + and CD8 + T-cell compartment in splenocytes of old mice (30-months-old) similar to that of young mice (12-months-old). RSV treatment resulted in a reduction of proinflammatory cytokines such as IFN-γ, IL-6, and TNF-α, and attenuated oxidative DNA damage with decreased 8-OHdG levels in the spleen of old mice (30-month-old) [329] . RSV treatment induced the expression of Klotho which is known as an aging suppressor gene in the mouse kidney [334] .
Treatment with RSV improved the downregulated mitochondrial biogenesis in the skeletal muscle and heart of mice fed a high-fat diet, with an increase in citrate synthase activity, mtDNA copy number, and mRNA expression of PGC-1α, mitochondrial mRNA expression of mitochondrial transcription factor A, and B2 (TFAM and TFB2M). The effect of RSV was abolished in animals lacking Sirt1, demonstrating that RSV function is mediated by Sirt1 [330] .
Although the treatment of low dose of RSV (0.0015 mg/kg of chow) to rats for 6 months had no effect on lifespan, it resulted in increased/improved aerobic capacity, time of exercise tolerance, and endothelium-dependent relaxation by acetylcholine, with decreased expression of p53 and increased telomere length and telomerase activity in aortic tissue [331] . Treatment attenuated age-induced oxidative stress, with an increase in glutathione and GPx activity in the liver of old mice [332] , and with induction of Mn-SOD activity, and reduction of hydrogen peroxide and lipid peroxidation levels in the skeletal muscle of middle-aged mice [333] .
On the other hand, some papers have reported that RSV has no significant effects on extending lifespan. For example, RSV had no effect on the lifespan of genetically heterogeneous mice [335] . Similarly, RSV supplementation (1.5 or 6 mg/mouse/day) from 12 months of age had no significant effect on survival in genetically heterogeneous mice [336] , nor did RSV extend the mean lifespan of Wrn mutant mice lacking the helicase domain of the WRN homolog [337] .
Reproductive system diseases
RSV treatment has been reported to improve the reproductive capacity of female mice and male rabbits. Female (14-15-months-old) mice supplemented with RSV for one year from 2 to 3-months-old maintained fertility (to reproduce pups), with an increase in follicle pool, number and quality of oocytes. Also, RSV treatment resulted in an increase of telomerase activity, telomere length, and age-related gene expression of Sirt1 which was reported to increase telomerase activity, and a decrease of the senescence marker p21 in ovaries, similar to those of young mice (2-3-months-old) [338] .
RSV treatment might improve erectile dysfunction induced by hypercholesterolemia, with increased vasorelaxation responses to acetylcholine in the corpus cavernosum isolated from cholesterol-fed male rabbits [339] .
RSV showed a protective effect on endometriosis. RSV treatment in female rats with surgically induced endometriosis reduced implant size and histological changes in the endometriotic foci, with a decrease of VEGF levels in the peritoneal fluid and plasma, MCP-1, levels in the peritoneal fluid, and VEGF (angiogenesis marker, angiogenesis as a pathological alteration in endometriosis) expression in endometriotic tissue [340] .
RSV treatment in female mice with surgically induced endometriosis resulted in a reduction in growth with reduced PCNA-and Ki67-positive stromal and glandular cells, and a decrease in angiogenesis of endometriotic lesions, with reduced microvessel density and CD31-positive endothelial cells in the neovascular lesions [341] .
However, it may be necessary to be cautious about intake RSV during pregnancy. RSV treatment decreased maternal weight, placental inflammation, and liver triglyceride deposition, while it increased glucose tolerance, and uterine artery volume blood flow in pregnant nonhuman primates. The fetal pancreatic mass was abnormally enlarged by RSV treatment [342] .
Irradiation injury
Total body irradiation (TBI) can lead to a decrease in survival, induction of bone marrow dysfunction and xerostomia. RSV exerted preventive effects with rodents undergoing TBI. RSV pretreatment increased survival, inhibited the reduction of WBCs and bone marrow nucleated cells (BMNs), and improved hematopoietic progenitor cells (HPCs) and hematopoietic stem cells (HSCs) with their clonogenic functions in bone marrow in mice undergoing TBI-induced long-term bone marrow injury [343] . In relation to molecular alterations, after TBI, RSV i) deceased ROS production and NOX4 expression, and increased SOD2 and GPx-1 expression in HSCs and HPCs, ii) decreased p16 and acetylated p53 expression and increased Sirt1 expression in HSCs, and iii) increased enzymatic activity of SOD2 and GPx-1 in BM-MNCs [343] .
RSV treatment attenuated acinar loss, ductal damage and cell necrosis, with an increase in glutathione levels and a decrease in MDA in both the parotid and submandibular glands of TBI-induced salivary gland dysfunction model with rats [344] .
Clinical studies
Early clinical studies conducted with RSV explored pharmacokinetic properties to provide a rudimentary understanding of metabolism, bioavailability, etc., with healthy subjects. More recently, as shown in Fig. 4 , the pharmacological features of RSV have been studied. Currently, the majority of clinical studies focus more on pharmacodynamics and, notably, clinical trials have been performed with overweight/obese, diabetic/metabolic syndrome, and cancer patients, as well as those with cardiovascular disease. A summary of clinical studies with RSV is listed in Table 11 .
Cancer
In patients with colorectal cancer who consumed RSV before surgical resection, tumor cell proliferation was reduced, suggesting that RSV may serve as a colorectal cancer chemopreventive agent [345] . SRT501 (micronized RSV) supplementation with colorectal cancer and hepatic metastases patients resulted in increased levels of cleaved caspase-3 in malignant hepatic tissue [346] . However, SRT501 had no effect on the levels of IGF-I, Ki-67, p-Akt (ser473), Akt1, p-GSK3, GSK3, p-ERK, ERK, p-JNK, JNK, β-catenin, survivin, Bcl-2, Bax, or PARP [346] . RSV supplementation decreased methylation of the tumor suppressor gene RASSF-1α which is directly related to a decrease in PGE 2 in adult women at increased breast cancer risk, demonstrating potential chemopreventive effects [347] . Also, RSV supplementation inhibited the phenotypic indices of CYP3A4, CYP2D6, and CYP2C9, while it induced the phenotypic index of 1A2 [348] .
Cardiovascular disease
RSV supplementation i) improved left ventricular diastolic function, endothelial function measured by flow-mediated dilatation, and red blood cell deformability, and ii) decreased LDL levels and platelet aggregation, and unfavorable hemorheological changes in patients with coronary artery disease [349] .
Stilvid® (RSV-enriched grape extract) supplementation exerted cardioprotective activity by decreasing oxidized LDL and apolipoprotein-B (ApoB) while increasing the ratio of non-HDLc (total atherogenic cholesterol load)/ApoB in statin-treated patients for primary cardiovascular disease prevention [350] .
RSV-rich grape supplement (GE-RSV) improved inflammatory and fibrinolytic status, with a decrease in high-sensitivity C-reactive protein, TNF-α, plasminogen activator inhibitor type 1, and IL-6/IL-10 ratio, and an increase in anti-inflammatory IL-10, in patients who were on statins for primary prevention of CVD and at high CVD risk [351] .
With the analysis of total urinary RSV metabolites (TRMs) in 1000 participants, RSV consumption was correlated with beneficial alterations in blood lipid profiles, fasting blood glucose, and heart rate [352] .
With stable-coronary artery disease patients, consumption of RSVcontaining grape extract (GE-RSV) resulted in an increase of the antiinflammatory serum adiponectin, and a decrease of thrombogenic PAI-1, with downregulation of gene expression in peripheral blood mononuclear cells (PBMCs) of: Connective tissue growth factor (CTGF), cardiotrophin-like cytokine factor 1 (CLCF1), placental growth factor (PGF), insulin-like growth factor binding protein 4 (IGFBP4), gastrin (GAST), melanoma inhibitory activity (MIA), wingless-type MMTV integration site family member 10A (WNT10A), surfactant protein B (SFTPB), collagen, type XVIII, alpha 1 (COL18α1), thyrotropin-releasing hormone (TRH), IL-1β-3, -8, -13, -17A, -17C, and -24, chemokine (C-C motif) ligand 3 (CCL3), CCL22, chemokine (C-X-C motif) ligand 2 (CXCL2), CXCL6, CX3CL1, sonic hedgehog (SHH), lymphotoxin alpha (LTA), IFNβ1 and TNF [353] .
RSV supplementation abolished the positive effects by physical exercise training with i) a decrease in maximal oxygen uptake, interstitial level of vasodilator prostacyclin, and ii) an increase in muscle thromboxane synthase, LDL, total cholesterol/HDL ratio and triglyceride concentrations in blood, without altering atherosclerosis marker VCAM-1 and Sirt1 [354] .
RSV supplementation led to the reduction in plasma IFN-γ and fasting insulin concentration [355] .
Diabetes
In some cases, RSV treatment has been reported to improve insulin sensitivity and glycemic control in type 2 diabetic patients. RSV treatment for 4 weeks decreased insulin resistance (homeostasis model of assessment for insulin resistance) and urinary ortho-tyrosine excretion, while it increased the pAkt:Akt ratio in platelets. On the other hand, it had no effect on parameters that relate to β-cell function (i.e., homeostasis model of assessment of β-cell function) [356] .
Treatment with RSV for 3 months improved mean hemoglobin A(1c), systolic blood pressure, LDL cholesterol, total cholesterol, urea nitrogen, and total protein in type 2 diabetes mellitus (T2DM). No significant changes in body weight and HDL cholesterol were observed in type 2 diabetes patients [357] .
RSV treatment for 4 weeks improved glucose metabolism (fasting plasma glucose was unchanged, but peak post meal and 3-hour glucose AUC declined) in older adults with impaired glucose tolerance (IGT) [358] .
RSV supplementation for 4 weeks in obese subjects had no effect on insulin sensitivity, endogenous glucose production and the turnover and oxidation rates of glucose, blood pressure, resting energy expenditure, oxidation rates of lipid, ectopic or visceral fat content, or inflammatory (TNF-α and NFκB) and metabolic (p-AMPK, p-ACC, GLUT4, and PGC-1α expressions) biomarkers [359] .
RSV-enriched (8 mg) grape extract (GE-RSV) supplementation for 1 year showed beneficial immunomodulatory effects in hypertensive subjects with T2DM. GE-RSV treatment altered molecular markers more than GE treatment when compared with placebo. GE-RSV reduced serum inflammatory markers (ALP and IL-6 levels) and proinflammatory cytokines [C-C motif chemokine ligand 3 (CCL3), IL-1β and TNF-α] in PBMCs, while it increased the expression of the transcriptional repressor [leucine-rich repeat flightless-interacting protein 2 (LRRFIP-1)] and miRNAs (miR-21, miR-663, miR-30c2) in PBMCs [360] .
RSV treatment in type 2 diabetic patients with newly diagnosed diabetic foot ulcers resulted in a reduction of diabetic ulcer size and plasma fibrinogen level [361] .
RSV treatment exerted beneficial effects on T2DM subjects with a decrease in systolic blood pressure, fasting blood glucose, hemoglobin A1c, and insulin resistance, and an increase in HDL [362] .
Obesity
In obese subjects, RSV exhibited a vascular protective effect [363, 367] , mimicked calorie restriction [364] , had an antioxidant effect [366] , protected from deregulated glucose tolerance [368] , had beneficial effects on hypertriglyceridemia [369] , and improved memory performance (maintenance of brain health) [370] .
RSV consumption increased flow-mediated dilatation of the brachial artery, a biomarker of endothelial function and cardiovascular health, in 19 overweight/obese men or post-menopausal women [363] .
RSV intake modified clinical signs and molecular markers with obese men, including a decrease in i) the sleeping and resting metabolic rate, ii) homeostasis model assessment (HOMA) index (an indication of insulin sensitivity), iii) adipose tissue lipolysis and plasma fatty acid and glycerol in the postprandial state, iv) intrahepatic lipid content, and v) circulating glucose, triglycerides, alanine-aminotransferase, leptin (satiety hormone), and TNF-α, and an increase in i) intramyocellular lipid levels, ii) p-AMPK (Thr172), Sirt1, and PGC-1α protein levels, iii) citrate synthase activity, and iv) muscle mitochondrial respiration on a fatty acid-derived substrate [364] . RSV supplementation did not change i) body composition (intra-abdominal fat volume and intrahepatic triglyceride content), ii) blood pressure, iii) heart rate, iv) resting metabolic rate, and v) plasma adipokine levels (adiponectin and leptin) or inflammatory markers (C-reactive protein [CRP] and IL-6) insulin sensitivity in the liver, skeletal muscle, or adipose tissue in non-obese, postmenopausal women with normal glucose tolerance [365] .
RSV supplementation reduced oxidative stress related markers in obese subjects. It decreased glutathione levels and increased oxidized LDLs, with alterations of gene expression related to oxidative stress and inflammation (decrease in PON3, CCR4, MAZ, and TFRC: increase PRDX1, FTH1, CCL5, UBB, HYPB, and HERPUD1) [366] .
In further clinical trials, RSV supplementation i) resulted in an increase in flow-mediated dilatation without affecting blood pressure, arterial compliance, and all components of the Stroop Color-Word Test in obese but otherwise healthy adults [367] , ii) had no impact on the levels of glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon in fasting plasma, while it suppressed postprandial plasma glucagon responses [368] , iii) reduced the production rate of triglyceride-rich apoB-48 and apoB-100 in overweight or obese individuals with mild hypertriglyceridemia [369] , and iv) improved memory performance with an increase in functional connectivity between the left posterior hippocampus and the medial prefrontal cortex, and improved glucose metabolism (decrease in HbA1c) in older adults [370] .
Others
RSV treatment elevated cerebral blood flow during task performance [371] , reduced the Global Acne Grading System (GAGS) score (the average area of microcomedones) of lesions in the face area caused by acne vulgaris [372] , and reduced pain scores, with a decrease in dysmenorrhea and pelvic pain, in patients using oral contraceptives with endometriosis. RSV treatment also downregulated the expression of aromatase and COX-2 in the eutopic endometrium of patients with endometriosis and pelvic pain [373] .
Finally, RSV treatment reduced CRP and triglyceride concentrations, and increased Total Antioxidant Status values in healthy smokers [374] , and exhibited a beneficial effect with a decrease in left ventricular function marker, N-terminal prohormone of brain natriuretic peptide (NTproBNP) with stable angina pectoris patients with asymptomatic or symptomatic left ventricular dysfunction [375] .
Discussion
As described herein, thousands of manuscripts have been published describing some aspect of resveratrol action, and generally the results are touted as correlating with some aspect of promoting better health. With the labyrinth of in vitro studies, however, it is frequently difficult to rationalize an actual relationship with pharmacological relevance since high concentrations of the parent compound are necessary to mediate a response. In most cases, achievable serum concentrations are many orders of magnitude below the concentrations used with in vitro studies. On the other hand, concentrations of metabolites such as RSV-3-O-glucuronide may be higher [262] , and the mean plasma level of RSV itself can be enhanced by processes such as micronization [263] . Also, recent studies have suggested that improvements in RSV bioavailability can be realized through combination with other compounds. For example, co-treatment with piperine improved the bioavailability of RSV, increased maximum serum concentrations in mice [377] , exerted a synergistic antidepressant-like effect with a mouse model [265] , and enhanced bioefficacy on cerebral blood flow in human subjects [378] . In addition, many other factors come into play, such as enzymatic reconversion of RSV metabolites to the parent compound and the effect of combining RSV with other drugs or compounds, so clearly, additional work is required.
Although all of this is interesting from an academic or practical point-of-view, detailed discussion of such topics is beyond the scope of the current review. In this review, we have concentrated on results obtained with animal models and clinical trials involving human beings. The ultimate endpoint of greatest interest is the biological response mediated with a living mammal and, frankly, the array of responses reported over the past 5 years is simply amazing (Fig. 5) . Amelioration of disease states and modulation of biomarkers is widespread over a large range of ailments. In many cases the in vivo investigations described herein allude to possible mechanisms, such as antioxidant, anti-inflammatory, and Sirt1 signal-activating capacities, but in actual fact it is difficult to pinpoint one truly critical target. Rather, it appears that the ability of RSV to mediate an overall response involves the weak modulation of a host of targets. As described previously, RSV is an extremely promiscuous molecule [379] . Taking advantage of this multifaceted pharmacological mode of action, additional uses of RSV have been suggested, such as exploitation as a probe for the rapid detection of Aβ and monitoring AD [380] .
Considering the broad range of responses, it is tempting to view RSV as a panacea. It should be borne in mind, however, the effects are often statistically significant but relatively weak, so a definitive response or cure is not a reasonable expectation. This leads to the notion of creating analogs with greater potency and efficacy [381] , but of course such an approach leads to greater developmental expenses, greater risk, and possibly adverse side-effects. It is noteworthy that RSV itself has not been found to exert adverse effects in animal models or clinical intervention studies.
As a distractor, a recent prospective cohort study, conducted in two villages in the Chianti area of Italy, revealed that total urinary RSV metabolite concentration did not correlate with inflammatory markers (serum CRP, IL-6, IL-1β, and TNF), cardiovascular disease, and cancer, nor was it predictive of all-cause mortality in 65-year-old or older subjects [376] . However, since this work is based on dietary levels, which are miniscule, the study has little bearing on RSV action. The same negative conclusions could be drawn in regard to the other 1600 compounds associated with the grape [7] , which are also present at very low concentrations, as well as the myriad of remaining constituents associated with the diet of free-living human beings.
In sum, to reach any definitive statements regarding the therapeutic potential of resveratrol, more detailed clinical trials with well-defined material and protocols are necessary. ClinicalTrials.gov lists approximately 80 RSV trials (https://clinicaltrials.gov/ct2/search/browse? brwse=intr_alpha_r; accessed September 9, 2014), so perhaps firmer expectations will be delineated over the next few years. 
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